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ABSTRACT 
 
In biological systems, bonded and non-bonded interactions determine the properties and 
the behavior of macromolecules.  Bonded interactions, such as ionic and covalent bonds, are 
the basis of chemical properties of biological molecules.  Enzymatic reactions, 
immunological recognition, and ion channel transformations involve bonded interactions.  
On the other hand, the non-bonded interactions, such as Van der Waals and weak electrostatic 
interactions, also determine some important properties of macromolecules, such as molecular 
conformation, the non-covalent binding interactions.  Changes in non-bonded interactions 
can significantly alter the structure and properties of a macromolecule, and thus influence its 
biological properties. 
Adenylosuccinate synthetase (ADSS) offers a good opportunity to measure the effect of 
non-bonded interactions.  Both IMP and 2’-deoxy-IMP are good substrates supporting 
identical binding affinities and maximal velocities; however, L-aspartate exhibits significant 
differences in binding affinities depending on which nucleotide is used as a substrate.  
Crystal structures of both complexes were identical except for the absence of the 2’-OH 
group in the dexoy-nucleotide complex.  The decrease in energy (~2 kcal/mole) in 
non-bonded interactions due to the loss of one atom explains the nearly 40-fold difference in 
the binding affinity of L-aspartate and an anlog of L-aspartate called hadacidin.  Single-atom 
cavities can profoundly influence the binding affinity of a ligand to a protein or the binding 
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of two proteins to each other. 
Sequence position 273 in Escherichia coli adenylosuccinate synthetase has a significant 
influence on the recognition of one of its substrates L-aspartate.  The mutation of Valine273 
to threonine, alanine, or asparagine causes 15-40 fold changes in the Km for L-asparate.  
Crystallizing these mutant proteins with and without ligands, and subsequent crystallographic 
investigations, revealed the basis for differences in Km values.  Although the Val273 in the 
active site doesn’t interact through hydrogen bonds with substrates or any other protein 
residues, it evidently has effect on the organization of the active site.  Km values are 
influenced by three mechanisms.  The replacement of valine by the threonine, introduces a 
polar side chain that closes the active site and prevents the binding of L-aspartate.  The 
mutation of position 273 to alanine, results in unfilled space in the active site which allows 
Arg305 to move into and occupy the binding site of L-aspartate.  Asparagine at position 273 
occupies too much space (sterically blocking the productive binding mode of l-aspartate and 
also interacting with surrounding amino acids.  All of these factors establish the requirement 
for valine at position 273, which is the reason Val273 is invariant over all known sequence of 
adenylossuciante synthetase. 
FBPase catalyzes the formation of fructose 1,6-bisphosphate to fructose 
1,6-bisphosphate and inorganic phosphate.  It exists in at least two quaternary states called 
R and T.  FBPase is active in its R-state, with its 4 subunits residing in a plane.  In the 
inactive T-state, stabilized by the binding of the alloseteric inhibitor AMP, causing the upper 
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subunit pair to twist 15 degrees relative to the bottom pair.  Different tetramers when 
combined exchange subunits over time.  Active site ligands such as Fru-6-P, Fru-1,6-P2, and 
Fru-2,6-P2 can limit certain subunit exchange reactions, and AMP can abolish exchange 
altogether.  In total, a mixture of two distinguishable FBPases leads to seven different 
tetramers.  Hybrid tetramers have been key in detemining the origin of cooperativity in the 
binding of ligands to FBPase, but the models for cooperative interactions rely on the proper 
assignment of structural type to each of the seven tetramers.  The assignments stem from 
reasonable assumptions that have gone unchallenged and without direct experimental 
verification.  The model for subunit exchange has the tetramer separating into “top” and 
“bottom” dimers, and then subsequently each dimer separates into monomers.  Verification 
of the model employed fluorescent probes and monitored the fluorescence change during 
subunit exchange.  By locating the probes at specific positions, the separation of tetramer 
into dimers, and dimers into monomer, could be monitored independently.  Furthermore, by 
quantifying the time-dependent change in fluorescence the elementary rate constants for 
forward and reverse reactions in tetramer/dimer and dimer/monomer equilibriums could be 
determined.  These constants allowed the simulation of subunit exchange reactions in 
agreement with observed fluorescence changes.  The approach here is innovative, broadly 
applicatble to any multisubunit system and easier to accomplish than comparable 
fluorescence resonance energy transfer experiments. 
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CHAPTER I. GENERATL INTRODUCTION 
The role of cavities in ligand selection 
The size, shape, and plasticity of binding sites are determinants of ligand binding affinity.  
In those systems for which electrostatics and/or hydrogen bonds are relatively unimportant, 
size and shape become the major factors in the docking of substrates and inhibitors to 
binding sites, and the rational design of drugs and ligand discrimination.  Plasticity 
associated with proteins in induced-fit models is merely a mechanism to couple 
conformational change to ligand binding interactions.  In the final bound state, the binding 
pocket generally closes over and hugs the ligand.  If a molecule is a misfit to the final shape 
of the binding site, induced conformational changes may not happen.  Steric hindrance is a 
well recognized factor in mechanisms of ligand selection; however, the role of small cavities 
introduced by a less than optimal fit of a ligand to its binding site are not as broadly 
appreciated by investigators.  Energy penalties due to a cavity equal in volume to a single 
atom range from 0.5–3 kcal/mol, leading to differences in dissociation constants of 2- to 
100-fold. 
Studies of T4 lysozyme provided some of the first data on the effects of cavities.  L99A 
mutant of T4 lysozyme introduces a cavity in the core of the enzyme.  The core is mostly 
non-polar and shielded from bulk solvent, resulting in a hydrophobic hole without hydrogen 
bonding potential.  The crystal structure of the L99A complex revealed a sphere of electron 
density within the constructed cavity.  The binding energies and Ka values were determined 
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for 16 ligands (1,2).  Those ligands with an extra ethyl or butyl group that filled the cavity 
had the highest affinity (2) (Fig 1, Table1).  Although the protein undergoes a movement of 
its backbone which may be partially responsible for the observed variation in affinities, 
ligands which most effectively occupy the cavity have the highest binding affinities. 
Cavities also play an important role in ligand binding to aminoacyl-tRNA synthetases 
(aaRSs).  Aminoacyl-tRNA synthetases catalyze the esterification of an amino acid to its 
cognate tRNA.  In order to maintain the fidelity of mRNA translation, each aaRS must 
discriminate between its cognate amino acid and other amino acids (3).  Fersht proposed the 
“double-sieve” (two-step substrate selection) model to explain the mechanism of the 
amino-acid selection.  Amino acids larger than the cognate amino acid are excluded by the 
aminoacylation site, serving as the “first, coarse sieve” (4).  Valyl-tRNA synthetase (ValRS) 
strictly discriminates the larger L-isoleucine at the aminoacylation site: Pro41 accommodates 
the side chains of L-valine and L-threonine, but has no room for the additional methyl group 
of L-isoleucine (5).  Amino acids with small side chains, however, present no steric barriers, 
but still have much lower affinities to enzyme that the cognate amino acid.  ValRS also 
activates and edits L-cysteine (6,7) and a noncanonical amino acid, L-α-aminobutyrate 
(6,8,9), which are one methyl group smaller than L-valine.  However, these non-cognate 
amino acids bind poorly to ValRS.  Glutaminyl-tRNA synthetase (GlnRS) binds weakly to 
glutamate.  Moreover, when the noncognate amino acid glutamate is bound to 
glutaminyl-tRNA synthetase tRNAGln binds some 60-fold more weakly than in the presence 
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of the cognate amino acid glutamine (10).  Unlike most tRNA synthetases, GlnRS does not 
catalyze the formation of the aminoacyl-adenylate intermediate without bound tRNA.  
Glutamate and glutamine bind to the amino acid pocket of the synthetase, but the negative 
charge of glutamate results in a strong electrostatic interaction with an arginyl side chain.  
That interaction draws the α-carboxyl group of glutamate away from the 3'-hydroxyl group of 
tRNAGln, causing non-optimal packing between tRNAGln, ATP and glutamate in the active 
site.  The effect is is observed kinetically on the Km for the amino acid and the kinetic on 
constant (kon) of tRNAGln. 
Cavities have significant implications for drug design.  An important criterion to 
determine the medical value of a drug is its specificity toward the target protein in order to 
minimize undesirable side-effects.  A well designed drug with good specificity can 
efficiently stimulate or inhibit the target, and have a suitable affinity to its binding site.  The 
binding cavity can identify the proper candidates: large molecules are excluded by steric 
hindrance and small ones, usually can’t bind efficiently in part due to the formation of 
cavities.  A century ago, Fischer and Ehrlich already used the "lock-and-key" analogy to 
describe such specificity.  During the last several years, we have witnessed huge progress in 
computational biology, which has improved the likelihood of success in rational drug design.  
Hundreds of thousands of compounds can be screened to find a promising new drug; 
however, qualified candidates are still hard to come by.  To improve the process of drug 
design, we need to better evaluate the negative impact of cavity formation.  Proper 
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consideration of the impact of cavity formation can eliminate false leads or indicate changes 
in a lead compound that enhance affinity. 
Recognition of L-aspartate and L-aspartate analogs by adenylosuccinate synthetase 
Adenylosuccinate synthetase (IMP: L-aspartate ligase (GDP-forming; ADSS); EC 
6.3.4.4, converts IMP and L-aspartate to adenylosuccinate, using GTP as an energy source. 
The synthetase participates in de novo purine nucleotide biosynthesis, the purine nucleotide 
cycle, and/or salvage pathways for nucleotides (11,12).  Evidence strongly implicates a 
two-step reaction mechanism for adenylosuccinate synthetases.  First, the γ-phosphoryl 
group of GTP is transferred to atom O-6 of IMP, forming 6-phosphoryl-IMP (6-PIMP). 
Second, the α-amino group of L-aspartate displaces the 6-phosphoryl group of 6-PIMP to 
form adenylosuccinate (11-16) (Fig 2).  The enzyme adopts a random sequential kinetic 
mechanism with a strong bias in favor of the association of L-aspartate after the formation of 
an enzyme•IMP•GTP complex (17) (Fig 3).  Mg2+ is generally required for the reaction; 
however, Ca2+ or Mn2+ could be alternative cofactors supporting catalysis at rates 5-fold less 
than Mg2+. 
Potent inhibition of adenylosuccinate synthetase generally terminates cell growth.  
Hadacidin (N-formyl-N-hydroxyglycine) inhibits only adenylosuccinate synthetase, being a 
competitive inhibitor with respect to L-aspartate (Ki ~10-6 M) (18) and a tight-binding 
analogue of L-aspartate in structural investigations of the synthetase (14,15). 
Vertebrates have two forms of adenylosuccinate synthetase: a basic isozyme, found 
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exclusively in muscle (17), is a component of the purine nucleotide cycle and the de novo 
pathway for the biosynthesis of AMP, and an acidic isozyme, which functions exclusively in 
de novo AMP biosynthesis (19-21).  The two isoforms in mouse are 75% identical in their 
amino acid sequences, and 40% identical to the enzyme from E. coli.  AMP is a weak 
inhibitor of the mouse basic isozyme, but a potent inhibitor of the mouse acidic isozyme and 
the E. coli enzyme (22).  On the other hand, in the presence of saturating levels of IMP, 
fructose-1,6-bisphosphate is a potent inhibitor of the basic isozyme, but only a weak inhibitor 
of the acidic isozyme (23).  Hence, in heavily exercised muscle, elevated levels of 
fructose-1,6-bisphosphate could inhibit the basic isozyme, but in others tissues and in 
bacteria, AMP is the likely feedback regulator of the synthetase. 
AMP and fructose-1,6-bisphosphate bind to the IMP site of the synthetase (23,24). 
Arguably then, the “regulatory” site of adenylosuccinate synthetase is contained within its 
active site.  Indeed, IMP stabilizes active synthetase dimers by interacting with residues 
from two subunits (25-27).  Moreover, the 5′-phosphoryl group of IMP, by hydrogen 
bonding with the side chain of Asparagine38, organizes residues of the GTP pocket some 30 
Å away (27).  The mutation of Asparagine38 to alanine lowers kcat 100-fold, but has no 
effect on the Km for any of the substrates (28).  An active site organized by IMP avoids the 
unproductive hydrolysis of GTP that would occur if the nucleoside triphosphate were to bind 
productively in the absence of IMP.  IMP is sufficient to organize the active site of the 
Escherichia coli synthetase alone, because it can bind to loops that define the active site of 
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the synthtease: Asparagine38 of the switch loop, Arginine303 of the aspartate loop, and several 
residues of the IMP loop, residues 120–130 (27). 
The comparison of ligand-free and ligated complexes of Escherichia coli 
adenylosuccinate synthetase reveals remarkable structural change in several loops (27).  
Loops 38–53 and 419–421 are ordered structures in the ligand-free state and move 
significantly when ligands bind.  Mg2+-GDP is an important factor in the conformational 
change of loop 38–53, making six hydrogen and metal-coordination bonds to this loop in 
ligated complexes.  Some backbone elements of loop 38–53 move up to 9 Å (14).  Loop 
120–130 and 299–304, close to IMP and L-aspartate respectively and disordered without 
ligands, undergo change to well-defined conformations (14,15). 
Threonine128, Threonine129, Valine273, Threonine300, and Threonine301 are conserved in 
amino acid sequences of adenylosuccinate synthetases.  Threonine128 and Threonine129 
interact with the 5′-phosphoryl group of IMP and Threonine301 hydrogen bonds directly to 
the carboxyl group of hadacidin (N-formyl N-hydroxyglycine; an analogue of L-aspartate).  
They undergo significant conformational change in response to the binding of ligands.  
These interactions are observed in ligated crystal structures of the synthetase from E. coli and 
mouse muscle (14,16).  Most surprising, however, is the significance of Valine273 to the 
recognition of L-aspartate.  Its mutation to threonine and alanine cause 15- and 30-fold 
increases in the Km for L-aspartate, and the mutation to asparagine causes a 40-fold increase 
(Table 2).  These mutations also reduce Ki values for analogues of L-aspartate by up to 
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40-fold (29).  Obviously, Valine273 is essential in binding L-aspartate, although crystal 
structures reveal no direct hydrogen bonds between Valine273 and L-aspartate. 
FBPase subunit exchange 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphophate 1-phosphohydrase, EC 
3.13.11;FBPase), a key regulatory enzyme of the gluconeogenic pathway, catalyzes the 
hydrolysis of fructose 1,6-bisphosphate (Fru-1,6-P2) to fructose 6-phosphate (Fru-6-P) and 
inorganic phosphate (for a review see (30-32)).  It is not only subject to the indirect 
regulation by glucagon and insulin, but also inhibited directly by AMP and fructose 
2,6-biphosphate (Fru-2,6-P2).  AMP binds to an allosteric and Fru-2,6-P2 to the active site of 
FBPase, with Hill coefficients of 2 and 1, repectively (30-34).  Although allosteric and 
active sites are at least 28 Å apart, the presence of Fru-2,6-P2 will increase the affinity of 
AMP to FBPase by at least 10-fold.  This property is called Fru-2,6-P2/AMP synergism.  In 
vivo, fructose-6-phosphate 1-kinase, which catalyzes the formation of Fru-1,6-P2 from ATP 
and Fru-6-P, combines with FBPase to define a futile cycle, and hence both enzymes are 
subject to coordinate regulation (35,36). 
Porcine liver FBPase is a tetramer with identical subunits (Mr=37,000).  Each subunit 
has a substrate binding site for Fru-1,6-P2, (or the inhibitor Fru-2,6-P2) and metal ions, and a 
distinct allosteric binding site for AMP (37-39).  The four subunits of the tetramer occupy 
each corner of a rectangle, labeled clockwise C1 through C4 (Fig 4).  Crystallographic 
structure determinations reveal FBPase in at least two distinct quaternary conformations, 
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called R and T.  R-state support catalysis and has the four subunits in a plane.  The binding 
of AMP induces a transition from the R-state to the inactive T-state, in which the C1-C2 
subunit pair rotates 15o with respect to the C3-C4 subunit pair about one of three intersecting 
twofold axes (39,40). 
 A proposed allosteric mechanism of AMP inhibition involves the conformation states of 
loop 52-72.  In the absence of AMP, the loop forms an engaged loop conformation, 
interacting with the active site (41,42).  Metals with products help the stabilization of this 
conformation.  The binding of AMP alone or with F26P2, putatively removes the loop from 
the active site, and stabilizes the disengaged loop conformation.  The engaged conformation 
of loop 52–72 only appears in R-state crystal structures and the disengaged conformer only in 
T-state structures.  However, disordered loop conformations have appeared in both the 
R-state in the absence of metals and/or active site ligands and the T-states of specific mutant 
FBPases (39,43-45).  Mutations of conserved residues in this loop 52–72 cause significant 
effects on catalysis and allosteric inhibition of catalysis by AMP (42,46). 
Distinct homotetramers of FBPase (engineered homotetramers having different subunit 
pIs) undergo spontaneous subunit exchange to form hybrid tetramers.  Anion-exchange 
chromatography can separate these tetramers by hybrid ratio: 4:0, 3:1, 2:2, 1:3, and 0:4 
(47,48).  (There are three different 2:2 hybrids that resolve into two peaks.  2:2 Hybrids 
with subunit C1 identical to subunit C2, but different from C3 and C4 separates by DEAE 
chromatography from 2:2 hybrids in which C1 and C2 are different.)  Active site ligands, 
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such as Fru-6-P, Fru-1,6-P2, and Fru-2,6-P2, selectively block subunit exchange at the level 
of individual subunits.  Only one kind of 2:2 hybrid is observed in the presence of such 
ligands (48).  As the 6-phosphoryl groups of these ligands bind to residues from both the C1 
and C2 subunits (C3 and C4 as well), preventing the dissociation of the dimer into monomers, 
the 2:2 hybrid that forms is of the type in which subunits C1 and C2 are identical.  AMP, on 
the other hand, abolishes all subunit exchange.  This inhibition of subunit exchange must 
differ from that due to active site ligands as AMP binds to one subunit exclusively (48).  
One possible model for the effect of AMP assumes an ordered mechanism for subunit 
exchange (Fig. 5): the tetramer dissociates initially to C1-C2 dimers by loss of the C1-C4 
(top-bottom) interface.  Then C1-C2 dimers dissociate into monomers.  If AMP blocks the 
formation of C1-C2 dimers, then all exchange reactions stop.  In non-denaturing 
polyacrylamide gels taken at progressive time points, 2:2 hybrids appear first, consistent with 
the ordered model (47,48). 
In order to prove our hypothesis, it is necessary to find a way to monitor this dynamic 
process.  Fluorescence is a good candidate due to its sensitivity.  However, the most 
common fluorescence technique, FRET, is not an appropriate method for our model.  A 
FRET system requires two different probes (donor and acceptor).  For each of them, the 
same four probes in one FBPase tetramer will interact with each other due to their close 
distance (~30-50 Å).  This interaction is called self-quenching (49-51).  For such 
circumstances, FRET signals will be obscurred by changes in the level of self-quenching.  
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Fortunately, the fluorescence signal from time-dependent changes in self-quenching provides 
information comparable to a FRET experiment, and is simpler to implement, as it requires 
only a single type of fluorescent probe. 
Fluorescence self-quenching has been known since 1888.  It occurs due to the existence 
of the same dye molecules in proximity, but the exact mechanism is not yet clear (49-51).  
Fluorescence from the dye is reduced when multiple dye molecules are bound to the same 
substrate.  The distance increase between dye molecules results in increasing fluorescence. 
Self-quenching has been used in studies of membrane fusion, ensembles of proteases and 
nucleases, of protein-dimer formation, and single molecule protein folding (52-55).  By 
modifying the FBPase enzyme, we can attach probes to special places of each subunit of the 
tetramer.  The dissociation of the FBPase into dimers and monomers increases the distance 
between probe molecules and leads to an increase in fluorescence.  By observing the time 
dependence of fluorescence change for distinct probe locations, we confirmed an ordered 
pathway of dissociation from tetramers to C1-C2 dimers, and then to monomers. 
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Table 1: The affinities of different ligands in T4 lysozyme L99A 
 
 
Ligand Ka×10-3(M-1) -△H (kcal/mol) -RTlnKa (kcal/mol) 
benzene 5.7±1.7 6.32±0.37 -5.19±0.16 
toluene 9.8±0.6 6.53±0.73 -5.52±0.04 
ethylbenzene 14.8±1.7 6.76±0.87 -5.76±0.07 
propylbenzene 55.2±2.0 9.97±0.05 -6.55±0.02 
n-butylbenzene 69.8±2.9 8.06±0.98 -6.7±0.02 
isobutylbenzene 51.0±44.9 7.09±0.35 -6.51±0.06 
 
 
 
Table 2: The kinetics assay of E.coli ADSS and its mutations in position 273 
 
 
Enzyme kcat KmGTP KmIMP KmL-aspartate Kihadacidin 
 (sec–1) µM µM mM µM 
Wild Type 1.00 ± 0.05 26 ± 2 28 ± 1 0.23±0.04 0.49±0.08
Threonine273 1.99 ± 0.02 45 ± 7 43 ± 4 3.4±0.2 15  ± 2 
Alanine273 1.00 ± 0.1 31 ± 3 17 ± 2 7 ±1 47  ± 2 
Asparagine273 0.050 ± 0.001 21 ± 2 24 ± 2 9± 1 N/A 
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Fig 1. Ligands used to test the difference of affinities in T4 lysozyme L99A. 
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Fig 2. A proposed two-step reaction mechanism for adenylosuccinate synthetase. 
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Fig 3. The structure view of E.coli adenylosuccinate synthetase in the presence of ligands. 
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Fig 4. The structure view of porcine FBPase tetramer in T-state. 
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Fig 5. A proposed mechanism of ordered dissociation pathway for FBPase tetramer. 
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ABSTRACT 
Adenylosuccinate synthetase catalyzes the first committed step in the de novo 
biosynthesis of AMP, coupling L-aspartate and IMP to form adenylosuccinate.  Km values of 
IMP and 2'-deoxy-IMP are nearly identical with each substrate supporting comparable 
maximal velocities.  Nonetheless, the Km value for L-aspartate and the Ki value for 
hadacidin (a competitive inhibitor with respect to L-aspartate) are 29- to 57-fold lower in the 
presence of IMP than 2'-deoxy-IMP.  Crystal structures of the synthetase ligated with 
hadacidin, GDP and either 6-phosphoryl-IMP or 2'-deoxy-6-phosphoryl-IMP are identical 
except for the presence of a cavity normally occupied by the 2'-hydroxyl group of IMP.  In 
the presence of 6-phosphoryl-IMP and GDP (hadacidin absent), the L-aspartate pocket can 
retain its fully ligated conformation, forming hydrogen bonds between the 2'-hydroxyl group 
of IMP and sequence-invariant residues.  In the presence of 2'-deoxy-6-phosphoryl-IMP and 
GDP, however, the L-aspartate pocket is poorly ordered.  Evidently, interactions involving 
the 2'-hydroxyl group of IMP maintain a protein conformation favorable to the binding of 
L-aspartate; however, the absence of the 2'-hydroxyl group in the fully ligated enzyme 
introduces a cavity with an approximate energy cost of 2.2 kcal/mol.  The unfavorable 
thermodynamics of cavity formation may be the major factor in destabilizing ligands at the 
L-aspartate pocket.  
ABBREVIATIONS 
The abbreviations used are: 6-PIMP, 6-phosphoryl-IMP; 2'-deoxy-6-PIMP, 2'-deoxy-6-phosphoryl-IMP. 
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INTRODUCTION 
Adenylosuccinate synthetase (IMP: L-aspartate ligase (GDP-forming); EC 6.3.4.4), 
converts IMP and L-aspartate to adenylosuccinate, using GTP as an energy source.  The 
synthetase participates in de novo purine nucleotide biosynthesis, the purine nucleotide cycle, 
and salvage pathways for nucleotides (1-3).  Evidence supports a two-step reaction 
mechanism for adenylosuccinate synthetases.  First, the γ-phosphoryl group of GTP is 
transferred to atom O-6 of IMP, forming 6-phosphoryl-IMP (6-PIMP).  Second, the α-amino 
group of L-aspartate displaces the 6-phosphoryl group of 6-PIMP to form adenylosuccinate 
(1-7).  The enzyme adopts a random sequential kinetic mechanism with a strong bias in 
favor of the association of L-aspartate after the formation of an enzyme•IMP•GTP complex 
(8, 9). 
Several potent inhibitors of adenylosuccinate synthetase terminate cell growth:  
Hydantocidin, a proherbicide activated specifically in plants, binds to the active site in 
combination with phosphate and GDP (10, 11, 12), the de novo purine nucleotide pathway 
converts L-alanosine into an analog of adenylosuccinate (13, 14), and hadacidin 
(N-formyl-N-hydroxyglycine) is a competitive inhibitor with respect to L-aspartate (15, 16).  
The synthetase also recognizes a limited number of substrate alternatives: 2'-deoxy-IMP and 
ß-D-arabinosyl-IMP for IMP; 2'-deoxy-GTP and GTPγS for GTP; and 
DL-threo-ß-fluoroaspartate, L-alanine-3-nitronate, L-cysteine sulfinate, L-alanosine, and 
hydroxylamine for L-aspartate (1, 3, 17).  The synthetase requires Mg2+ as a cofactor, albeit 
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Ca2+ or Mn2+ support catalysis at rates 5-fold less than Mg2+ (1, 3). 
Vertebrates have two forms of adenylosuccinate synthetase: a basic isozyme, found 
exclusively in muscle, is a component of the purine nucleotide cycle and the de novo 
pathway for the biosynthesis of AMP, and an acidic isozyme, which functions exclusively in 
de novo AMP biosynthesis (18-23).  The two isoforms in mouse are 75% identical in their 
amino acid sequences, and 40% identical to the enzyme from E. coli.  AMP is a weak 
inhibitor of the mouse basic isozyme, but a potent inhibitor of the mouse acidic isozyme and 
the E. coli enzyme (23).  On the other hand, in the presence of saturating levels of IMP, 
fructose 1,6-bisphosphate is a potent inhibitor of the basic (muscle) isozyme, but only a weak 
inhibitor of the acidic isozyme (23).  Hence, in heavily exercised muscle, elevated levels of 
fructose 1,6-bisphosphate could inhibit the basic isozyme, but in other tissues and in bacteria, 
AMP is the likely regulator of the synthetase. 
AMP and fructose 1,6-bisphosphate bind to the IMP site of the synthetase (23, 24).  
Arguably then, the “regulatory” site of adenylosuccinate synthetase is within its active site.  
Indeed, IMP stabilizes active synthetase dimers by interacting with residues from two 
subunits (5, 23, 25).  Moreover, the 5'-phosphoryl group of IMP, by hydrogen bonding with 
the side chain of Asn38, organizes residues of the GTP pocket some 30 Å away (26).  The 
mutation of Asn38 to alanine lowers kcat 100-fold, but has no effect on the Km for any of the 
substrates (27).  An active site organized by IMP avoids the unproductive hydrolysis of 
GTP that would occur if the nucleoside triphosphate were to bind productively in the absence 
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of IMP. 
Here we report a role for IMP in the recognition of L-aspartate.  Recombinant 
synthetases from E. coli and mouse muscle have similar Km values for 2'-deoxy-IMP and 
IMP.  Both enzymes, however, exhibit 29- to 57-fold increases in their Km values for 
L-aspartate (KmL-aspartate) and Ki values for hadacidin (Kihadacidin) when 2'-deoxy-IMP replaces 
IMP.  Crystal structures of the E. coli synthetase, having bound GDP, hadacidin and either 
6-PIMP or 2'-deoxy-6-PIMP, reveal no conformational differences within experimental 
uncertainty; the absence of the 2'-hydroxyl group introduces only a cavity.  On the other 
hand, crystalline complexes of the mouse muscle synthetase without hadacidin, but having 
bound GDP and either 6-PIMP or 2'-deoxy-6-PIMP, differ significantly.  Disorder in the 
L-aspartate pocket is correlated with the loss of hydrogen bonds normally associated with the 
2'-hydroxyl group of IMP.  Although disorder in the L-aspartate pocket may contribute to 
increases in Kihadacidin and KmL-aspartate, cavity formation in the fully ligated enzyme by itself 
can account for the observed increases in kinetic parameters. 
EXPERIMENTAL 
Materials— All reagents, including GTP, IMP, L-aspartate, bovine serum albumin, and 
DEAE-Sepharose were from Sigma unless noted otherwise.  Plasmids for the expression of 
enzyme are those employed in previous investigations (23, 27). 
Expression and Purification of Mouse Muscle and E. coli Adenylosuccinate 
Synthetase—The recombinant E. coli and mouse basic isozyme were prepared as described 
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previously (27, 28).  Enzyme purity was assayed by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE).  Investigations here employed the mouse muscle isozyme 
with its N-terminal polyhistidyl tag in place.  The presence of the polyhistidyl tag has no 
effect on the kinetics of the mouse basic isozyme (28); however, only the tagged form of 
protein has been crystallized (24, 28, 29).  Recombinant E. coli adenylosuccinate synthetase 
used here does not have an affinity tag (27). 
Enzyme Assays— Protein concentrations were determined by the method of Bradford 
(30), using bovine serum albumin as a standard.  Enzyme activity was determined by the 
change in absorbance at 290 nm at 22 °C as described previously (8).  Using up to 1 µg/mL 
enzyme, the reaction was linear for at least 1 min.  Km and Vmax values for each substrate 
were obtained by holding the other two substrates at saturating levels (100 µM GTP, 300 µM 
IMP or 2'-deoxy-IMP, and 2 mM L-aspartate with IMP or 200 mM L-aspartate with 
2'-deoxy-IMP) and varying the concentration of the third substrate.  In determining Km 
values, initial concentrations of GTP varied systematically from 5–100 µM, those of IMP (or 
2'-deoxy-IMP) from 25–300 µM, and those of L-aspartate from 0.1–2 mM (for IMP) or 1–96 
mM (for 2'-deoxy-IMP).  In determining the Ki values of hadacidin, concentrations of GTP 
and IMP were maintained at saturating levels (100 and 300 µM, respectively) as initial 
concentrations of L-aspartate and hadacidin varied from 0.125–2 mM and 0.25–16 µM, 
respectively.  Ki values of hadacidin in the presence of 2'-deoxy-IMP employed fixed initial 
concentrations of GTP and 2'-deoxy-IMP of 100 and 300 µM, respectively, as initial 
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concentrations of L-aspartate and hadacidin varied from 4–64 mM and 10–160 µM, 
respectively.  For the E. coli enzyme, the assay buffer contained 20 mM Hepes, pH 7.7, and 
6 mM magnesium chloride, and for the mouse enzyme 20 mM Hepes, pH 7.2, and 8 mM 
magnesium acetate.  All data were analyzed with the computer program GraFit (31).  
Models for competitive, noncompetitive, uncompetitive and mixed inhibition were fit to 
hadacidin inhibition data. 
Crystallization— Crystals were grown by the method of hanging drops.  The mouse 
muscle enzyme crystallized from equal parts of a protein solution (10 mg/ml protein in 50 
mM Hepes, pH 7.5, 50 mM NaCl, 1 mM dithiothreitol (DTT), 0.5 mM EDTA, 10 mM GTP 
and 10 mM 2'-deoxy-IMP) and a precipitant solution (100 mM Hepes, pH 7.0, 200 mM 
magnesium acetate, 12–14% (w/v) polyethylene glycol 8000 or 12–17% (w/v) polyethylene 
glycol 3350).  Crystals of the E. coli enzyme grew from equal parts of a protein solution (10 
mg/ml protein in 50 mM Hepes, pH 7.0, 50 mM NaCl, 1 mM dithiothreitol (DTT), 0.5 mM 
EDTA, 5 mM GTP, 5 mM 2'-deoxy-IMP, 2 mM hadacidin, and 10 mM magnesium acetate) 
and a precipitant solution (100 mM Hepes, pH 7.0, 200 mM magnesium acetate, 12–16% 
(w/v) polyethylene glycol 8000).  In all experiments, droplet volumes were 6 µL, and wells 
contained 500 µL of the precipitant solution.  Equal dimensional prisms of 100 microns 
appeared within 3 days at 22 °C.  Crystals were transferred to a solution of 50 mM Hepes, 
pH 7.0, 100 mM magnesium acetate, 27% (w/v) polyethylene glycol 8000, and 21% (v/v) 
glycerol and then frozen in liquid nitrogen. 
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Data Collection, Model Building, and Refinement— Data for the mouse muscle complex 
was collected at Beamline 9-2 of the Stanford Synchrotron Radiation Laboratory, using a 
ADSC Quantum 4 CCD detector.  The wavelength of radiation was 0.979 Å, and the 
temperature of data collection was 120 K.  Data reduction employed Denzo/Scalepack (32).  
Data for the E. coli complex were collected at Iowa State University on a Rigaku R-AXIS 
IV++ image plate detector using an Osmic confocal mirror system (CuKa radiation) and a 
sample temperature of 100 K.  Data reduction employed the software package CrystalClear 
(33).  Intensities were converted to structure factors using the CCP4 program TRUNCATE 
(34).  Structures were solved by molecular replacement, using the program AmoRe (35) and 
models for the fully ligated mouse muscle enzyme (Protein Data Bank identifier 1LON, (29)) 
and E. coli enzyme (Protein Data Bank identifier 1CGO, (7)).  Model building and 
refinement employed the programs XTALVIEW (36) and CNS (37), respectively.  Force 
constants and parameters of stereochemistry came from Engh and Huber (38).  Criteria for 
the addition of water molecules were identical to those of previous studies (5-7).  Estimates 
of coordinate error used the method of Luzzati (39).  Evaluation of stereochemistry of the 
refined model employed PROCHECK (40).  Superposition of structures employed software 
from the CCP4 package (41) or XTALVIEW (36). 
Estimates of Cavitation Energies— The contribution to the total potential energy of the 
2'-hydroxyl group of 6-PIMP in the fully ligated complexes of the E. coli and mouse muscle 
synthetases was calculated by using AutoDock 3.0 (42).  Van der Waals’ interactions were 
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determined between the 2'-O atom and atoms within a sphere of radius 10 Å.  
Lennard-Jones parameters in AutoDock 3.0 are not available for interactions involving Mg2+; 
however, as Mg2+ is approximately 9.8 Å from the 2'-hydroxyl group of 6-PIMP in 
synthetase structures, the contribution of a single Mg2+-O contact to the total energy is 
negligible. 
RESULTS 
Enzyme Purity and Kinetics— Proteins used in assays and crystallization were at least 
95% pure on the basis of sodium dodecylsulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE).  2'-Deoxy-IMP is a substrate of the synthetase (17), but prior to the present 
study no information was available regarding the kinetics of an adenylosuccinate synthetase 
reaction supported by 2'-deoxy-IMP.  Km values for 2'-deoxy-IMP and IMP (Table 1) for 
both the E. coli and mouse muscle enzyme are equal within experimental uncertainty.  All 
other parameters are equivalent for the two reactions except those associated with L-aspartate 
and hadacidin.  KmL-aspartate increases 57- and 29-fold, and Kihadacidin increases 35- and 44-fold, 
for E. coli and mouse muscle enzymes, respectively, in reactions that use 2'-deoxy-IMP 
instead of IMP.  Evidently, the E. coli and mouse muscle adenylosuccinate synthetases, 
broadly representative of microbial and vertebrate systems, have a mechanism to distinguish 
ribonucleotide and 2'-deoxy-ribonuceleotide substrates.  That mechanism is indirect; the 
recognition of the nucleotide itself is equally robust, but in some way the 2'-hydroxyl group 
of the ribonucleotide is an essential determinant in the recognition of L-aspartate and for 
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high-affinity binding of hadacidin. 
Existing Crystal Structures of Ribonucleotide Complexes of E. coli and Mouse Muscle 
Synthetases— Crystal structures of synthetases from E. coli and mouse muscle exist in 
ligand-free and fully ligated complexes (7, 24, 29).  For the latter, GDP, 6-PIMP, hadacidin 
(as an analog of L-aspartate) and Mg2+ are in the active site.  In addition, a structure is 
available for the 6-PIMP•GDP complex for the mouse muscle enzyme (29) and for the 
Arg303→Leu E. coli enzyme, which has low affinity for hadacidin and a high Km for 
L-aspartate (7, 43).  In fully ligated complexes, the 2'-hydroxyl group of IMP hydrogen 
bonds with a backbone carbonyl group of a peptide link between sequence invariant residues 
(Val273 and Gly274 in the E. coli synthetase and Val305 and Gly306 in the mouse muscle 
enzyme).  The 2'-hydroxyl group also hydrogen bonds with an arginyl side chain (Arg303 
and Arg335 in the E. coli and mouse muscle enzymes, respectively).  Arg303 (and probably 
the corresponding position in the mouse muscle isozyme Arg335) is essential for the 
recognition of L-aspartate, as its mutation to leucine causes a 200-fold increase in the Km for 
L-aspartate (43).  Hadacidin makes only nonbonded contacts with 6-PIMP in fully ligated 
complexes. 
Fully Ligated 2'-Deoxy-ribonucleotide Complex of the E. coli Synthetase (Protein Data 
Bank identifier 2GCQ)— Statistics of data collection and refinement for crystals of the E. 
coli synthetase grown in 2'-deoxy-IMP, GTP, hadacidin and Mg2+ are in Table 2.  The 
active site contains a single Mg2+ to which are coordinated 2'-deoxy-6-PIMP, GDP, and 
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hadacidin (Figure 1).  Electron density associated with 2'-deoxy-6-PIMP is strong, but no 
observable density is associated with what would be the position of a 2'-hydroxyl group 
(Figure 1).  Interactions between active site ligands and the protein are identical to those of 
the 6-PIMP, GDP, hadacidin and Mg2+ complex (PDB identifier 1CGO) (Figure 2).  
Specifically, as the focus here is on the binding of hadacidin, the oxygen atom of its 
N-formyl group coordinates Mg2+ (2.27 Å), and its β-carboxyl group hydrogen bonds with 
Thr301 OG1 (2.68 Å), Arg303 HN2 (2.83 Å), and backbone amide groups of Thr300 (3.03 Å) 
and Thr301 (2.66 Å).  The N-hydroxyl group of hadacidin is 3.45 Å and 2.52 Å from the 
side chains of Arg305 and Asp13, respectively.  The aforementioned distances in the 
6-PIMP and 2'-deoxy-6-PIMP complexes exhibit a root-mean-squared deviation of 0.22 Å, 
well within the estimated uncertainty in coordinates of 0.25 Å, and no distance between 
corresponding atoms in the two complexes exceeds 0.4 Å.  In fact, the principal difference 
in the fully ligated E. coli structures is the void left by the absence of the 2'-hydroxyl group 
in the 2'-deoxy-IMP complex. 
Partially Ligated 2'-Deoxy-ribonucleotide Complex of the Mouse Muscle Synthetase 
(Protein Data Bank identifier 2DGN)— Statistics of data collection and refinement appear in 
Table 2 for the mouse basic enzyme crystallized with 2'-deoxy-IMP, GTP and Mg2+.  The 
active site contains a single Mg2+ that coordinates 2'-deoxy-6-PIMP and GDP.  Electron 
density associated with the ligands is strong, but none is present at what would be the 
position of the 2'-hydroxyl group. 
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Unlike the fully ligated structures of the E. coli and mouse muscle enzymes, the partially 
ligated complexes of the mouse basic isozyme exhibit significant conformational differences 
in their L-aspartate binding pockets (Figure 3).  The mouse muscle enzyme with 6-PIMP, 
GDP and Mg2+ (Protein Database Base identifier 1LNY) has a dimer in the asymmetric unit.  
Backbone carbonyl groups of residues 332–334 of chain B hydrogen bond in a lattice contact 
that stabilizes the aspartate binding loop (residues 330–336) some 5 Å away from its position 
in fully ligated structures of the mouse muscle and E. coli enzymes (7, 29).  Distances from 
Thr332 OG1 to Asn68 O and Gly70 N are 9.46 and 9.95 Å, respectively, about 6.2 Å longer 
than corresponding distances in the fully ligated mouse muscle enzyme.  Arg335 
(equivalent to Arg303 in the E. coli synthetase) and the backbone carbonyl group of Val305 
(corresponding to Val273 of the E. coli enzyme) do not hydrogen bond with the 2'-hydroxyl 
group of the ribonucleotide in chain B.  The aspartate loop of chain A participates in a 
different set of lattice contacts involving backbone carbonyl groups of residues 333 and 334, 
as well as a side chain stacking interaction involving Trp329.  Nonetheless, the 
conformation of the aspartate loop in chain A is similar to that of the fully ligated structure.  
Specifically, Arg335 and the backbone carbonyl of Val305 hydrogen bond with the 
2'-hydroxyl group of IMP, as observed in fully ligated systems.  Distances in chain A from 
Thr332 OG1 to Asn68 O and Gly70 N are 6.81 and 6.77 Å, respectively, about 3.5 Å longer 
than those in the fully ligated mouse muscle enzyme. 
In contrast to the 6-PIMP•GDP•Mg2+ complex, the asymmetric unit of the 
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2'-deoxy-6-PIMP•GDP•Mg2+ mouse muscle complex has but a single subunit.  The enzyme 
is still a dimer, however, its axis of molecular symmetry coincides with a crystallographic 
axis of twofold symmetry.  The 6-PIMP•GDP•Mg2+ and 2'-deoxy-6-PIMP•GDP•Mg2+ 
complexes have nearly equivalent structures (root mean square deviation for superimposed 
Cα carbons of 0.4 Å) except for their aspartate loops.  Interactions involving Arg335 and 
the backbone carbonyl of Val305 are absent as expected.  Moreover, the aspartate loop is 
withdrawn from the active site: distances from Thr332 OG1 to Asn68 O and Gly70 N are 
9.46 and 9.85 Å, respectively.  The conformation of the aspartate loop in the 
2'-deoxy-6-PIMP•GDP•Mg2+ is much like that of the aspartate loop in chain B of the 
6-PIMP•GDP•Mg2+ structure, but the outwardly displaced loop cannot be attributed to a 
lattice contact. 
Energy differences in 6-PIMP and 2'-deoxy-6-PIMP complexes— The crystal structures 
of the fully ligated complexes 6-PIMP and 2'-deoxy-6-PIMP of the E. coli synthetase are 
identical to within experimental error.  Hence, the energy of interaction involving the 
2'-hydroxyl group in the fully ligated 6-PIMP complex is an estimate of the energy penalty 
due to the absence of that group.  As fully ligated 6-PIMP complexes are available for the E. 
coli and mouse muscle synthetases (PDB identifiers 1CG0 and 1LON, respectively), the 
interaction energies can be calculated for both systems.  The interaction energies of the 
2'-hydroxyl groups in the E. coli and mouse muscle systems from AutoDock 3.0 (Table 3) 
are nearly identical, in harmony with the nearly identical sequences and structures of the two 
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complexes in the region of consideration (29). 
DISCUSSION 
The kinetic mechanism for the E. coli enzyme is rapid-equilibrium random (8, 9).  
Hence, KmL-aspartate is a reasonable approximation of the equilibrium constant governing the 
dissociation of L-aspartate from the enzyme•IMP•GTP•L-aspartate•Mg2+ complex.  
Moreover, changes in Kihadacidin are consistent with those of KmL-aspartate, further evidence of 
rapid equilibrium kinetics.  L-Aspartate and hadacidin then dissociate more readily from the 
2'-deoxy-IMP complex than from the IMP complex, and this is true to the same extent for the 
E. coli and mouse muscle enzymes. 
A factor in the relatively weak association of L-aspartate and hadacidin in the presence of 
2'-deoxy-IMP is the loss of hydrogen bonds involving the side chain of a conserved arginine 
(positions 303 and 335 in E. coli and mouse muscle enzymes, respectively) and the backbone 
carbonyl group of a conserved valine (positions 273 and 305 in E. coli and mouse muscle 
enzymes, respectively).  Complexes of 6-PIMP, GDP and Mg2+ of the mouse muscle 
enzyme (Protein Data Bank identifier 1LNY, space group C2) indicate a predisposition to 
form hydrogen bonds involving the 2'-hydroxyl group of 6-PIMP even in the absence of 
hadacidin.  When these hydrogen bonds are intact (as in chain A of 1LNY), the L-aspartate 
loop assumes a conformation much like that of the fully ligated complexes of the synthetase.  
Lattice contacts observed in the mouse muscle crystal structure (1LNY), however, introduce 
an element of uncertainty.  We do not know whether hydrogen bonds involving the 
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2'-hydroxyl of 6-PIMP form in solution in the absence of L-aspartate.  If such hydrogen 
bonds do form, they have no influence on the Km of IMP, and hence the free energy from 
such interactions must go toward stabilizing a subset of conformations favorable to the 
binding of L-aspartate. 
A more intriguing contribution to the elevated kinetic parameters for L-aspartate and 
hadacidin is the cavity that replaces the 2'-hydroxyl group of the fully ligated 
2'-deoxy-ribonucleotide complex.  Water does not occupy the site left vacant by the absent 
2'-hydroxyl group, and the protein structure does not relax to fill the void.  Hence, the cost 
of cavity formation to a first approximation is the loss of all interactions involving the 
2'-hyroxyl group in the fully ligated complex.  Assuming the entropy is not changed 
significantly in a thermodynamic transition from a 6-PIMP to a 2'-deoxy-6-PIMP complex 
(and we see no evidence from the crystal structures to suggest differences in conformational 
entropy), the calculated difference in potential energy is a fair approximation of the free 
energy differences in the ribonucleotide and deoxy-ribonucleotide complexes.  The energy 
difference ranges from 2.2 to 2.3 kcal/mol, which would increase dissociation constants for 
hadacidin by 41- to 49-fold.  The calculated increases are close to those of observed kinetic 
parameters, and suggest that cavity formation is the primary cause of the observed behavior. 
Curiously, the absence of the 2'-hydoxyl group only influences kinetic parameters of 
hadacidin and L-aspartate.  One would expect an increase in the Km of 2'-deoxy-IMP 
relative to IMP, as the loss in hydrogen bonding potential and nonbonded interactions are due 
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to the absence of a functional group covalently attached to the nucleotide.  An explanation 
of this phenomenon may rest with the kinetic mechanism of the synthetase.  Although that 
mechanism is random, isotope exchange kinetics indicate that in 90% of synthetase turnovers 
L-aspartate is the last substrate to bind to the enzyme (9).  Evidently, when IMP binds to the 
active site, its base encroaches upon the L-aspartate pocket (29).  Phosphorylation at the 
6-position of IMP introduces numerous interactions that “bend” the purine base away from 
the L-aspartate pocket (24).  Hence, the formation of 6-PIMP removes steric barriers to the 
productive binding of L-aspartate.  As the cavity due to the absent 2'-hydroxyl group does 
not exist until L-aspartate binds (and for the vast majority of turnovers, binds last of the three 
substrates), the negative impact of cavity formation is felt entirely by the amino acid 
substrate. 
The unfavorable free energy of cavity formation may be a factor in the weak binding of 
small amino acids (glycine, alanine and serine) to the synthetase (Aaron ver Heul and 
Richard B. Honzatko, unpublished) and may account for the relatively weak inhibition of 
adenylosuccinate synthetases by succinate.  Succinate has the carboxyl groups of 
L-aspartate, but lacks the steric encumbrance of an α-amino group, and yet KmL-aspartate is 
4-fold lower than the Kisuccinate for the E. coli enzyme (44).  If, however, the succinate 
complex of the synthetase leaves a void where an α-amino group should be, its Ki would be 
high relative to the Km of L-aspartate. 
Cavity formation as a means of substrate discrimination is not unprecedented.  In fact, 
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the selection of the correct amino acid by aminoacyl-tRNA synthetases is due at least in part 
to the penalty in placing a hydrogen atom in a binding pocket designed for a larger functional 
group.  L-Valine suffers approximately a 3.4 kcal/mol penalty relative to L-isoleucine in 
binding to the recognition pocket of isoleucyl-tRNA synthetase, and a penalty of similar 
magnitude occurs in the binding of L-α-aminobutyric acid to valyl-tRNA synthetase (45-47).  
Energy shortfalls for the association of L-alanine to cysteinyl-tRNA synthetase and 
L-phenylalanine to tyrosyl-tRNA synthetase are even greater (9.1 and 7.0 kcal/mol, 
respectively), and result in effective substrate discrimination without recourse to editing 
mechanisms (47, 48).  The high energy penalties of tRNA synthetases, attributed to the loss 
of interactions of a missing carbon, oxygen or sulfur atom, infer a rigid pocket for the amino 
acid side chain, surrounded by densely packed protein atoms.  By comparison, the energy 
penalty caused by 2'-deoxy-IMP (2.2–2.3 kcal/mol) is relatively modest, and clearly, one 
observes “empty space” in the vicinity 2'-hydroxy group even for the correct substrate 
(Figure 4). 
Cavity formation is a significant consideration in the design of tight-binding inhibitors.  
In the case of adenylosuccinate synthetase and perhaps for other multi-substrate systems, it 
may be possible to design or discover “complementary” inhibitors, molecules that by 
themselves inhibit weakly, but when combined result in potent inhibition.  In fact, 
hydantocidin owes its potent inhibition (Ki~20 nM) of adenylosuccinate synthetase to its tight 
packing with phosphate and GDP in the active site (12).  A screen of adenylosuccinate 
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synthetase in its complex with 2'-deoxy-6-PIMP and GDP or fructose 1,6-bisphosphate and 
GDP could lead to tight-binding alternatives to hadacidin. 
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Table 1.  Kinetic parameters for recombinant adenylosuccinate synthetases from E. 
coli and mouse muscle using IMP and 2'-deoxy-IMPa. 
Enzyme E. coli Mouse muscle 
IMP reaction: 
 kcat (sec–1) 1.00±0.05 5.4±0.4b 
 KmIMP (µM) 28±1 45±7b 
 KmGTP (µM) 26±2 12±2b 
 KmL-aspartate (µM) 230±40 140±20b 
 Kihadacidin (µM) 0.49±0.08 0.32±0.05
2'-Deoxy-IMP reaction: 
 kcat (sec–1) 0.96±0.05 5.5±0.2 
 Km2'-deoxy-IMP (µM) 41±4 58±8 
 KmGTP (µM) 21±1 15±2 
 KmL-aspartate (mM) 13±5 4±0.2 
 Kihadacidin (µM) 17±3 14±3 
 
Table 1.  Footnotes. 
aConditions of assay are in the experimental section. 
bFrom reference (23). 
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Table 2.  Statistics of data collection and refinement 
 
Complex 
E. coli: GDP• 
2'-deoxy-6-PIMP•hadacidin
Mouse muscle: GDP• 
2'-deoxy-6-PIMP 
Space group P3221 P43212 
Unit cell parameters: 
  a (Å) 80.59 70.11 
  b (Å) 80.59 70.11 
  c (Å) 158.5 199.0 
Resolution limits (Å) 25–2.0 16−2.4 
No. of reflections collected 285,758 244,020 
No. of unique reflections 39,551 20,371 
Completeness of data (%), 
overall/last shella 96.4/78.5 98.9/98.9 
Rmergeb, overall/last shella 0.055/0.265 0.100/0.415 
No. of refls. in refinementc 39,498 19,121 
No. of atoms 3,384 3,408 
No. of solvent sites 169 128 
R/Rfreed 0.224/0.251 0.198/0.262 
Mean B values (Å2): 
  protein 38 35 
  ligands 36 27 
Root mean square deviations: 
  Bond lengths(Å) 0.006 0.006 
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  Bond angles(°) 1.3 1.2 
  Dihedral angles(°) 23 23 
  Improper dihedral angles(°) 0.83 0.85 
 
Table 2.  Footnotes. 
aResolution range for the last shell is 2.0−2.07 Å for the E. coli complex and 2.4−2.5 Å for 
mouse muscle complex. 
bRmerge=∑j∑i|Iij–<Ij>|/∑i∑jIij, where i runs over multiple observations of the same intensity 
and j runs over crystallographically unique intensities. 
cAll data for which |Fobs|>0. 
dR-factor=∑||Fobs|–|Fcalc||/∑|Fobs|, |Fobs|>0. 
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Table 3.  Energy calculations involving the 2'-hydroxyl group of 6-PIMP in fully ligated 
complexes of E. coli and mouse muscle adenylosuccinate synthetase. 
Interaction
Type 
Number of
interactions
Energy 
(kcal/mol)
E. coli: 
O-C 107 -1.487 
O-N  45 -0.371 
O-O  50 -0.481 
Total: 202 -2.339 
Mouse muscle: 
O-C 108 -1.247 
O-N  47 -0.481 
O-O  44 -0.463 
Total 199 -2.190 
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FIGURE LEGENDS 
Figure 1.  The 2'-deoxy-6-PIMP•GDP•hadacidin•Mg2+ complex.  The left panel 
provides a view of a single subunit of the dimer with bound ligands.  The right panel shows 
electron density from an omit map covering 2'-deoxy-6-PIMP, using a contour level of 1.5-σ 
and a cutoff radius of 1.5 Å.  The labels Had and d-6-PIMP represent hadacidin and 
2'-deoxy-6-PIMP, respectively.  Parts of this figure were drawn with MOLSCRIPT (49). 
Figure 2  Stereoview of superpositions of fully ligated complexes of E. coli 
adenylosuccinate synthetase.  The complex of 6-PIMP, GDP, hadacidin and Mg2+ (white 
with thin lines) nearly overlays that of 2'-deoxy-6-PIMP, GDP, hadacidin and Mg2+ (black 
with bold lines).  Labels Had and d-6-PIMP represent hadacidin and 2'-deoxy-6-PIMP, 
respectively.  The viewing orientation is that of Figure 1.  This figure was drawn with 
MOLSCRIPT (49). 
Figure 3.  Stereoview of superpositions of partially ligated complexes of mouse muscle 
adenylosuccinate synthetase.  Complexes of 6-PIMP, GDP and Mg2+ (Chain A, white with 
thin lines, and Chain B, gray with medium lines) are superimposed on the complex of 
2'-deoxy-6-PIMP (black with bold lines).  Label d-6-PIMP represents 2'-deoxy-6-PIMP.  
The viewing orientation is that of Figure 1.  This figure was drawn with MOLSCRIPT (49). 
Figure 4.  Space filling models of the fully ligated complex of the E. coli synthetase.  
Packing voids in the vicinity of the 2'-hydroxy group of 6-PIMP (left) and in its absence in 
the 2'-deoxy-6-PIMP complex (right) are indicated by dark outlines of the atoms determining 
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to the void.  The viewing orientation is that of Figure 1.  This figure was drawn with 
PyMOL (50). 
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CHAPTER III 
 
The Role of Valine273 in the Recognition of L-Aspartate in Adenylosuccinate 
Synthetase 
Yang Zhou, Herbert J. Fromm and Richard B. Honzatko* 
Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, 
Ames, IA 50011 
ABSTRACT 
Adenylosuccinate synthetase, with the hydrolysis of GTP, catalyzes the first step of de 
novo purine nucleotide biosynthesis in the formation of adenylosuccinate from L-aspartate 
and IMP.  Valine in position 273 of the enzyme from Escherichia coli is conserved over all 
sequences of adenylosuccinate synthetase.  Mutation of this site in the synthetase from E. 
coli reveals the significant role of Valine273 in the recognition of L-aspartate, even though it 
cannot hydrogen bond with the substrate.  Mutations of Valine273 to alanine, threonine, or 
asparagine increase the Km for L-aspartate from 15- to 40-fold, and decrease the Ki for 
dicarboxylate analogues of L-aspartate by up to 40-fold.  Here we show the size and apolar 
properties of residue 273 are responsible for proper conformational change of the L-aspartate 
loop in response to the binding of L-aspartate.  Structure-based mechanisms, by which the 
residue influences substrate recognition, are presented here to explain the conservation of 
Valine273. 
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INTRODUCTION 
In the de novo biosynthesis of AMP, adenylosuccinate synthetase (IMP: L-aspartate 
ligase (GDP-forming); EC 6.3.4.4) catalyzes the first reaction: generating adenylosuccinate 
from IMP and L-aspartate.  The liagse reaction is energetically unfavorable and is coupled 
with the hydrolysis of GTP to favor product formation in a two step reaction mechanism 
(1-3): The γ-phosphoryl group of GTP is transferred to the O-6 atom of IMP, forming 
6-phosphoryl-IMP (6PIMP).  Then, the α-amino group of L-aspartate displaces the 
6-phosphoryl group of 6PIMP to form adenylosuccinate (SAMP) (1-7).  The kinetic 
mechanism is random sequential with a strong bias in favor of the association of L-aspartate 
after the formation of an enzyme-IMP-GTP complex (8).  Mg2+ is an essential cofactor in 
the reaction (2). 
 Besides its role in de novo biosynthesis of purine nucleotides, adenylosuccinate 
synthetase participates in salvage pathways for nucleotides (1-3).  The position of 
adenylosuccinate synthetase in the nucleotide metabolism makes it important to the growth 
of cells: the synthetases are targets in the development of drugs in the treatment of cancer and 
infectious disease. 
 The active form of the synthetase from Escherichia coli is a homodimer (9).  IMP, is an 
essential factor in the formation and stability of the homodimer.  The 5′-phosphoryl group 
of IMP hydrogen bonds with the Arginine143 from the symmetry-related subunit of the dimer.  
Mutation of Arginine143 significantly lowers the affinity of IMP for the enzyme and abolishes 
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ligand-induced dimerization of the synthetase (2).  IMP in the form of its phosphorylated 
intermediate 6-PIMP, binds Mg2+ and three dynamic loops of the active site (L-aspartate loop, 
loop 120-130 and loop 38-53).  IMP alone is sufficient to organize the active site of the E. 
coli synthetase alone (10) through its interactionbetween the 5′-phosphoryl group and 
Asparagine38. 
 The comparison of ligand-free and ligated complexes of E. coli adenylosuccinate 
synthetase reveals remarkable conformational change in several loops (3).  Loops 38–53 
and 419–421, ordered structures in the ligand-free enzyme, exhibit significant movement 
when ligands bind. Some backbone elements of loop 38-53 move up to 9 Å (5).  Mg2+-GDP 
seems an important factor in stabilizing the active conformation of loop 38-53, making six 
hydrogen and metal coordination bonds to this loop.  Loop 120-130 and 299-304, close to 
the IMP and L-aspartate pockets, respectively, and disordered without ligands, assume 
well-defined conformations in the presence of IMP and L-aspartate (5,6).  Conformational 
change in the L-aspartate loop 299-304 and the binding of L-aspartate are coupled with the 
binding of IMP.  The hydrogen bond from atom O2′ of IMP to Arginine303 NH2 can draw 
the L-aspartate loop into a conformation ready to bind L-aspartate.  The loss of this 
hydrogen bond, by the replacing IMP with 2′-deoxy-IMP, increases the Km for L-aspartate by 
40-fold (11). 
 Threonine128, Threonine129, Valine273, Threonine300, and Threonine301 are sequence 
conserved, indicating they probably have important functions.  Threonine128 and 
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Threonine129 interact with the 5′-phosphoryl group of IMP and Threonine301 hydrogen bonds 
directly to the carboxyl group of hadacidin (N-formyl N-hydroxyglycine; an analogue of 
L-aspartate) (5,7).  However, the apparent significance of Valine273 to the recognition of 
L-aspartate is puzzeling.  Threonine and alanine in position 273 cause 15- and 30-fold 
increases, respectively, in the Km for L-aspartate, and the mutation to asparagine causes a 
40-fold increase.  At the same time, it reduces Ki values for analogues of L-aspartate by up 
to 40-fold (12).  Obviously, Valine273 is essential to the recognition of L-aspartate although 
its side chain cannot hydrogen bond. 
 Hadacidin is a competitive inhibitor with respect to L-aspartate (13), and provides the 
basis in crystal structures for modeling interactions between L-aspartate and the active site.  
Here we report four new crystal structures of mutant E. coli adenylosuccinate synthetase in 
which position 273 is alanine or threonine.  In its ligated complexes, the side chain of 
Threonine273 exhibits several interactions that don’t exist for wild type enzyme.  
Threonine273 OG1 hydrogen bonds with Arginine305 and thus closes the L-aspartate loop onto 
the binding pocket for L-aspartate.  The Alanine273 mutant has the L-aspartate loop 
conformation of the wild type complex; however, the absence of the two γ-CH3 groups 
leaves excess room in the L-aspartate binding pocket, allowing the side chain of Arginine305 
to fill the space normally occupied by L-aspartate.  Both mutations force L-aspartate to 
expend more binding energy to organize the active site into the catalytically product state. 
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EXPERIMENTAL 
Materials— Restriction enzymes came from Promega. Pfu DNA polymerase and E. coli 
strain XL-1 blue were obtained from Stratagene. Phenyl-Sepharose CL-4B came from 
Amersham Biosciences, Inc. All reagents, including GTP, IMP, L-aspartate, bovine serum 
albumin, and DEAE-Sepharose were from Sigma unless noted otherwise.  
Molecular Biology— The construction of the Escherichia coli adenylosuccinate 
synthetase mutants on position 273 is described previously (12). 
Purification of Enzyme from Escherichia coli— The synthetase was prepared as 
described previously from a genetically engineered strain of E. coli. (15).  Enzyme purity 
exceeded 95% as determined by SDS-polyacrylamide gel electrophoresis (data not shown). 
Enzyme Assay—Protein concentration was determined by the Bradford method (16), using 
bovine serum albumin as the standard. Enzyme activity was determined at an absorbance of 
290 nm and 22 °C as described previously (17).  For the E. coli adenylosuccinate synthetase, 
the assay buffer contained 20 mM Hepes, pH 7.7, and 6 mM magnesium chloride.  Using up 
to 1 µg/ml enzyme, the reaction was linear for 1 min. Km and Vmax values for each substrate 
were obtained by holding the other two substrates at saturating levels (100 µM for GTP, 300 
µM for IMP, and 2000 µM for L-aspartate) and varying the third substrate.  GTP was varied 
from 5 to 100 µM, IMP varied from 25 to 500 µM, L-aspartate varied from 100 to 1000 µM 
and hadacidin varied from 0.25 to 100 µM. All of the kinetic data were analyzed with the 
computer program GraFit (18). 
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Crystallization— Crystals were grown by the method of hanging drops.  Equal parts of 
a protein solution (10 mg/ml of protein in 50 mM Hepes, pH 7.0, 50 mM NaCl, 1 mM 
dithiothreitol, 0.5 mM EDTA) and precipitant solution (200 mM MgCl2, 100 mM HEPES, 
pH 7.0, 12-14% polyethylene glycol 8000) were mixed in 6-µl droplets.  The wells 
contained 500 µl of the precipitant solution.  Equal dimensional prisms of 100 microns 
appeared within 3 days at 22 °C. The crystals were transferred in three steps (10-min 
intervals) to solutions containing 100 mM MgCl2, 50 mM HEPES, pH 7.0, 27% (w/v) 
polyethylene glycol 8000, and glycerol at 7, 14, and 21% (v/v) and then frozen in liquid 
nitrogen. 
Data Collection, Model Building, and Refinement— Data were collected at Beamline 9-2 
of Stanford Synchrotron Radiation Laboratory, using the CCD detector, ADSC Quantum 4.  
The wavelength of x-radiation was 0.979 Å, and the temperature of data collection was 120 
K. Data reduction was done with Denzo/Scalepack package (19).  Other data were collected 
on a Rigaku R-AXIS IV++ image plate detector using an Osmic confocal mirror system 
(CuKa radiation) and a sample temperature of 100 K.  Data reduction employed 
CrystalClear software.  Structures were solved by molecular replacement with the program 
AmoRe (20).  The initial model was the E. coli synthetase (Protein Data Bank identifier 
1CG0) (7).  Model building and refinement employed the programs XTALVIEW (21) and 
CNS (22), respectively.  Force constants and parameters of stereochemistry came from 
Engh and Huber (23).  Criteria for the addition of water molecules were identical to those of 
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previous studies (5-7).  Estimates of coordinate error used the method of Luzzati (24).  
Evaluation of stereochemistry of the refined model employed PROCHECK (25).  
Superposition of structures employed software from the CCP4 package (26) or XTALVIEW 
(21). 
RESULTS 
 In order to explore the role of the amino acid at position 273 in E. coli adenylosuccinate 
synthetase mutant enzymes Valine273→Threonine and Valine273→Alanine were constructed.  
The mutant enzymes were assayed and crystallized in partial ligation (GDP, 6PIMP, and 
Mg2+) or in full ligation (GDP, 6PIMP, Mg2+, and hadacidin).  The results of kinetic and 
structural analyses are in Tables 1&2.  Km values for L-aspartate and Ki values for hadacidin 
increase significantly, whereas kcat, and Km values for IMP and GTP remain comparable to 
those of the wild-type enzyme. 
Threonine273 Adenylosuccinate Synthetase, Fully Ligated— This structure is nearly 
identical to that of the wild type enzyme, fully ligated (Figure 1).  The RMSD for these two 
structures based on Cα atoms is 0.17 Å, the approximate level for the uncertainty in atomic 
coordinates.  The superposition of structures reveals identical backbone and side-chain 
conformations.  Atom O2′ of IMP O2’ is 2.7 Å from the atom NH2 of Arginine303, 
indicative of a hydrogen bond.  The χ1 angle of Threonine273 differs from that of Valine273 
of the wild-type complex (–46° vs. –124° in the wild-type enzyme).  Threonine273 OG1 
forms a hydrogen bond with the OD2 of Aspartate13 (3.1 Å), as well as with a water molecule 
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in the active site (3.1 Å).  There are also two potential hydrogen bonds between 
Threonine273 OG1 and hadacidin atom OB and Arginine305 NE, both with distances of 3.6 Å.  
These extra interactions do not change the conformation of residues (such as Arginine305 and 
Aspartate13) that interact with ligands (hadacidin or water molecules). 
Alanine273 Adenylosuccinate Synthetase, Fully Ligated— The RMSD for the Cα atoms 
from the wild type and Alanine273 complexes is 0.25 Å.  Moreover, the corresponding 
RMSD for the Cα atoms from the Alanine273 and Threonine273 complexes is 0.24 Å.  The 
absence of two γ-CH3 groups in the Alanine273 enzyme creates a small cavity around the 
ß-carbon atom: a hemisphere of ~4 Å radius around the ß-carbon atom is clear of contacts 
(Figure 1).  The loss of two methyl groups without a compensating conformational change 
in the enzyme to enhance the packing density of atoms could result in energy differences of 5 
kcal/mole, more than enough to account for the increase in Km for L-aspartate. 
Threonine273 Adenylosuccinate Synthetase, Partially Ligated— GDP, IMP and Mg2+, 
have the same conformation as in the fully ligated complex, and Threonine273 itself, has the 
same conformation (Figure 2).  Other differences, however, are evident between the 
partially ligated Threonine273 complex and the wild-type complex.  In the wild-type system 
atom O2′ of IMP hydrogen bonds with atom NH2 of Arginine303.  In the partially liagted 
Threonine273 complex this structure, atom O2′ of IMP is 4.1 Å from atom NH2 of Arginine303.  
At the same time, atom OG1 of Threonine273 hydrogen bonds with atom NE of Arginine305.  
This interaction cannot exist in the wild type system.  Perhaps as a consequence of the 
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Threonine273-Arginine305 interaction, the L-aspartate loop closes over the active site.  We 
see such closed conformations in fully ligated complexes, but this is the first instance of a 
cosed active site in a partially ligated complex. 
Alanine273 Adenylosuccinate Synthetase, Partially Ligated— The partially ligated 
Alanine273 structure is like the wild-type enzyme with respect to the conformation of the 
L-aspartate loop (Figure 3).  Atom O2′ of IMP is 3.0 Å from atom NH2 of Arginine303, and 
L-aspartate loop stands off form the active site; however, specific side chains exhibit 
differences.  Arginine305 swings almost 30 degrees toward to Alanine273 in the binding site.  
Atom NE of Arginine305 binds (2.9 Å) to the backbone carbonyl of Arginine303, and atom 
NH2 of Arginine305 forms hydrogen bonds with atom OD2 of Aspartate13 (2.7 Å) and a water 
molecule (3.4 Å).  Atom NH1 of Arginine305 also hydrogen bonds with atom OD2 of 
Aspartate13 (2.6 Å). Of these interactions, only the last one exists in partially ligated 
complexes of the wild-type enzyme. 
DISCUSSION 
 There are two important differences between partially ligated complexes of the 
Threonine273 mutant and wild-type enzymes (Figure 2).  First, the Threonine273 complex 
lacks the IMP O2′-Arginine303 NH2 hydrogen bond.  This hydrogen bond in the wild-type 
enzyme positions Arginine303 favorably for the binding of the β-carboxyl group of L-aspartate.  
Second, the L-aspartate loop is like the L-aspartate loop in the fully ligated complex, that is, 
in its closed conformation.  Stabiliztion of the closed conformation in the absence of 
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L-aspartate is due evidently to the interaction between atom OG1 of Threonine273 and the side 
chain of Arginine305, the latter being critical to the binding of the α-carboxyl group of 
L-aspartate.  Both of these conditions are unfavorable to the binding of L-aspartate, and not 
suprisely, the Km for L-aspartate for the Threonine273 enzyme is high relative to that of the 
wild-type enzyme.  In contrast, the fully ligated complexes of the wild-type and 
Threonine273 enzymes are almost identical.  As the fully ligated complexes are the closest 
structural approximations of the substrate-bound complexes, their similarity suggests 
comparable energies for transition states.  The structures then are consistent with 
comparable kcat values determined from activity assays in the presence of saturating 
substrates. 
 Destabilization of the Alanine273-L-aspartate complex relative to the wild-type complex 
differs appreciable from that of the Threonine273 complex.  The partially ligated structure of 
the Alanine273 complex is very similar to that of the wild-type enzyme.  Some 
organizational differences exist, particularly with respect to the conformation of Arginine305, 
but for the most part L-aspartate has free access to the active site (Figure 3).  In the fully 
ligated complex, however, the Alanine273 enzyme has a less densely packed active site than 
that of the wild-type enzyme because of the absence of two methyl groups from the side 
chain at position 273.  Hence, a cavity exists in the active site in the fully ligated comlex of 
the Alanine273 enzyme that does not exist in the fully ligated complex of the wild-type 
enzyme.  The loss of non-bonded contacts due to a less tightly packed active site raises the 
 62
Km for L-aspartate.  Nonetheless, the conformation of substrates in the fully-ligated complex 
of Alanine273 and the wild-type enzymes are virtually identical.  Hence, the kcat values are 
similar for the two systems. 
The basis for sequence conservation in position 273 ultimately rests with the 
optimization of packing density in the active site because of a complementary fit of the 
isopropyl group of value, which can be acehived on only the isoteric side chain of threonine.  
In the presence of side chains smaller than that of valine, the active site has destabilizing 
internal voids in its fully ligated state.  In the presence of threoine, however, the active site 
closes in the absence of L-aspartate.  Hence, more binding energy of the L-aspartate 
interaction must go toward “lifting” the partially-ligated ground state to the fully-ligated 
transition state. 
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Table 1: Statistics of data collection and refinement. 
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Table 2:  Kinetic parameters for recombinant adenylosuccinate synthetases from E. coli. 
 
Enzyme Kcat KmGtp KmImp KmAsp KiHad 
  µM µM mM µM 
Wild Type 1.00 ± 0.05 26 ± 2 28 ± 1 0.23±0.04 1 
Threonine273 1.99 ± 0.02 45 ± 7 43 ± 4 3.4±0.2 15  ± 2 
Alanine273 1.00 ± 0.1 31 ± 3 17 ± 2 71 47  ± 2 
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FIGURE LEGENDS 
Figure 1.  Stereoview of superpositions of fully ligated complexes of wild type, Thr273, 
Ala273 E. coli adenylosuccinate synthetases.  Active sites of Thr273 and Ala273 
complexes (Thr273 complex, white with thin lines, and Ala273 complex, gray with medium 
lines) are superimposed on the active site of wild type ccomplex (1CG0, black with bold 
lines).  This figure was drawn with MOLSCRIPT. 
Figure 2.  Stereoview of superpositions of fully ligated and partially ligated complexes 
of Thr273 E. coli adenylosuccinate synthetase.  Active site of fully ligated Thr273 
complexes (white with thin lines) is superimposed on the active site of partially ligated 
Thr273 ccomplex (black with bold lines).  The viewing orientation is that of Figure 1.  
This figure was drawn with MOLSCRIPT. 
Figure 3.  Stereoview of superpositions of fully ligated and partially ligated complexes 
of Ala273 E. coli adenylosuccinate synthetase.  Active site of fully ligated Ala273 
complexes (white with thin lines) is superimposed on the active site of partially ligated 
Ala273 complex (black with bold lines). The viewing orientation is that of Figure 1.  This 
figure was drawn with MOLSCRIPT. 
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Fig. 1.  Zhou, et al. 
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Fig. 2.  Zhou, et al. 
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Fig. 3.  Zhou, et al. 
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CHAPTER IV 
 
Time-dependent Fluorescence Change as a Probe of Subunit Exchange Kinetics 
in Porcine Fructose-1,6-Bisphosphatase 
Yang Zhou, Herbert J. Fromm and Richard B. Honzatko* 
Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, 
Ames, IA 50011 
ABSTRACT 
Fructose-1,6-bisphosphatase (FBPase) governs a control point in gluconeogenesis, the 
hydrolysis of fructose 1,6-bisphosphate (Fru-1,6-P2) to fructose 6-phosphate (Fru-6-P) and 
inorganic phosphate (Pi).  Mammalian FBPases are stable homotetramers in solution, and 
yet subunits exchange spontaneously between distinct homotetramers to produce hybrid 
heterotetramers.  Fluorescent probes (eosin-5-iodoacetamide), attached specifically to 
subunits, exhibit self-quenching if brought into proximity by the subunit arrangement of the 
FBPase tetramer.  Elimation of self-quenching occurs when the tetramer dissociates into 
subunits upon dilution or if unlabeled subunits exchange with probe-labeled subunits.  By 
monitoring the time-dependent fluorescent change, disruption of the C1-C4 interface of the 
tetramer occurs without a time lag; however, disruption of the C1-C2 interface occurs after a 
lag of approximately 30 minutes.  Forward/reverse rate constants for subunit 
dissociation/association reactions account for time-dependent fluorescent changes due to the 
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dilution of labeled tetramer and also to subunit exchange between modified and wild-type 
tetramers.  The exchange pathway begins with the formation of C1-C2 dimers from 
tetramers, followed by the formation of single subunits from C1-C2 dimers.  The pathway 
observed here is consistent with subunit arrangements previously assigned to hybrid 
heterotetramers of FBPase.  Moreover, the most kinetically liable interface of the 
mammalian tetramer (C1-C4 interface) corresponds to the interface of FBPase from 
Escherichia coli subject to stabilization by allosteric activators. 
Key Words: Protein-protein interactions, Kinetic mechanisms, Protein self-assembly, 
Subunit exchange, Protein engineering, Macromolecular dynamics 
INTRODUCTIOIN 
Fructose-1,6-bisphosphatase (D-fructose 1,6-bisphosphate 1-phosphohydrolase, EC 
3.1.3.11; FBPase) is a key regulatory enzyme in the gluconeogenesis, catalyzing the 
hydrolysis of fructose 1,6-bisphosphate (Fru-1,6-P2) to fructose 6-phosphate (Fru-6-P) and 
inorganic phosphate (Pi) (1-3).  FBPase, together with fructose-6-phosphate 1-kinase, 
composes a futile cycle in the gluconeogenic/glycolytic pathways (4, 5).  AMP and fructose 
2,6-biphosphate (Fru-2,6-P2) inhibit the enzyme by binding to the allosteric and active sites 
respectively.  Inhibition of FBPase by AMP is nonlinear (Hill coefficient of ~2) and 
noncompetitive with respect to Fru-1,6-P2, whereas inhibition by Fru-2,6-P2 is linear and 
competitive with respect to substrate (1-3, 6, 7). Fru-2,6-P2 increases the binding affinity of 
AMP to FBPase by as much as 10-fold (8).  AMP/Fru-2,6-P2 synergism stems from distinct 
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mechanisms of conformational change that lead to similar inhibited end states of the enzyme 
(8-10). 
FBPase is a tetramer of identical subunits (Mr=37,000).  Each subunit has binding sites 
for Fru-1,6-P2 (or Fru-2,6-P2) and metal ions, defining the active site, and a distinct AMP 
binding site, which is at least 28 Å from the nearest active site (11-13).  The four subunits of 
the tetramer adopt an approximate square-planar arrangement.  Subunit C1 occupies the 
upper-left position, with subunits C2 through C4 following clockwise (Figure 1).  FBPase 
exists in at three quaternary states called R, I and T, distinguished by the rotation of subunit 
pair C1-C2 relative to C3-C4 about the molecular twofold axis that lies between subunits C1 
and C2 as well as C3 and C4.  With the R-state defining a subunit pair rotation of 0°, the 
I-state (observed in complexes of porcine FBPase with Fru-2,6-P2) and the T-state (observed 
in complexes with AMP or AMP and Fru-2,6-P2 combined) have subunit-pair rotation angles 
of 13 and 15°, respectively. (14-16) 
Loop 52–72 plays an important role in the allosteric mechanism of AMP inhibition.  In 
the absence of AMP, the loop forms an engaged loop conformation, interacting with the 
active site (17, 18).  The binding of AMP to its allosteric pocket putatively removes the loop 
from the active site, and stabilizes the disengaged loop conformation.  Mutations of 
conserved residues in Loop 52–72 cause significant effects on catalysis and allosteric 
inhibition of catalysis by AMP (18, 19). 
Previous work reveals different homotetramers of FBPase when mixed undergo 
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spontaneous subunit exchange.  Initially, a hybrid tetramer forms with two subunits from 
each of two homotetramers, followed later by the formation of hybrid tetramers that combine 
one subunit of tagged t forming hybrid tetramers to a large extent separable by 
anion-exchange chromatography (20, 21).  AMP eliminates subunit exchange, through 
presumably the formation of the T-quaternary state.  The disengaged loops in T-state crystal 
structures participate in hydrophobic interactions that involve residues from three of four 
subunits of the FBPase tetramer.  Active site ligands, such as Fru-6-P, Fru-1,6-P2, and 
Fru-2,6-P2, block the exchange at the level of individual subunits, but allow the exchange of 
subunit dimers (21).  The 6-phosphoryl groups of these ligands bind to residues from both 
the C1 and C2 subunits (C3 and C4 as well), and hence, the assignment of hybrid tetramers 
of FBPase formed in the presence of these 6-phosphoryl ligands has assumed the 
immutability of the C1-C2 (and C3-C4) subunit pair.  Significant conclusions regarding the 
function of FBPase rests on the assumption of a stable C1-C2 dimer in exchange processes in 
the presence of 6-phosphoryl ligands (21).  In fact, current models for the AMP-induced 
conformational change in FBPase (21) would be invalid if the C1-C4 subunit pair were the 
stable dimer.  Hence, direct verification of the pathway of subunit places current models of 
allosteric action in mammalian FBPases on a firm footing. 
Self-quenching is the decrease in the change of fluorescence intensity as fluorophore 
concentrations increase.  Self-quenching occurs under conditions (such as high 
concentration) where fluorophore molecules interact.  Although the physical mechanism is 
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unclear, quenching may result from transient excited-state interactions (collisional quenching) 
or from formation of nonfluorescent ground-state species (22).  The self-quenching of 
carboxyfluorescein involves energy transfer to nonfluorescent dimmers (23).  Investigators 
has used fluorescence self-quenching to probe ensemble protease and nuclease activities (24), 
membrane fusion (25), protein-dimer formation (26), and single molecule folding (27).  
Here, the fluorescence self-quenching arising from a specific placement of probes in the 
FBPase tetramer, reveals the pathway of subunit exchange in mammalian FBPase.  Probes 
on individual subunits are in proximity near a specific subunit interface.  Rapid dilution of 
such labeled tetramers of FBPase results in a time-dependent rise in fluorescence due to the 
dissociation of the tetramer into dimers or single subunits.  Alternatively, the rapid mixing 
of unlabled and labeled tetramer also results in a time-dependent increase in fluorescence as 
labled subunits recombine with unlabled subunits to form hybrid tetramers of FBPase.  As 
self-quenching requires conjugation of only one type of fluorophore with the macromolecule, 
the technique is relatively easy to implement in comparison to FRET which requires labeling 
with appropriately matched fluorophores. 
Time-dependent change in fluorescence self-quenching of strategically labeled subunits 
of a mutant FBPase directly confirms the first kinetic step in the dissociation of the tetramer 
into C1-C2 and C3-C4 subunit pairs.  After a substantial time lag, subunit exchange 
processes involving the disruption of the C1-C2 and C3-C4 interfaces becomes measurable.  
Forward and reverse rate constants for the dissociation of tetramers into C1-C2 and C3-C4 
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dimers and the dissociation of C1-C2/C3-C4 subunit pairs into monomers reproduce time 
dependent fluorescence change.  The kinetic mechanism of subunit exchange is consistent 
with a initial rapid dissociation of the tetramer into C1-C2 dimers, followed by a much 
slower dissociation of C1-C2 dimers into monomeric subunits. 
EXPERIMENTAL 
Materials— Fru-1,6-P2, Fru-2,6-P2, NADP+, DEAE-Sepharose and Cibacron 
Blue-Sepharose came from Sigma.  Glucose-6-phosphate dehydrogenase and 
phosphoglucose isomerase were from Roche Applied Sciences.  Kanamycin sulfate from 
Gibco, E. coli strains BL21(DE3) and chemically competent DH5α from Invitrogen, 
isopropyl-β-D-thiogalactopyranoside (IPTG) from Anatrace, 2′-deoxyribonucleoside 
triphosphates and restriction endonuclease DpnI from New England Biolabs, PfuTurbo DNA 
polymerase from Stratagene, QIAprep Spin Miniprep kit for plasmid isolation from Qiagen, 
oligonucleotides from IDT, and eosin-5-iodoacetamide from Molecular Probes.  The pET 24 
vector containing the insert coding for porcine FBPase came from previous work (20).  All 
other chemicals were of reagent grade. 
Construction of mutant FBPases— Directed mutagenesis employed protocols from 
Stratagene using the Polymerase Chain Reaction (PCR), PfuTurbo DNA polymerase, 
2′-deoxyribonucleoside triphosphates, template DNA (pET 24 vector containing the porcine 
FBPase insert), and the following primers: 
5′-CAGCTGCTCAACTCGCTGGCCACCGC -3′, 
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5′-GGTGAATGGAGTCAATTCCTTCATGCTGGACCCG-3′, 
5′-GGGTAAATACGTGGTCGCTTTTGATCCCCTCG-3′, 
5′-GGATCGTCGAACATCGACGCCCTTGTGTC-3′, 
5′-GGTGAATGGAGTCAATGCCTTCATGC-3′, and 
5′-GACTGCTATACGAAGCTAACCCGATGGC-3′, 
The primers insert codons for alanine (bold typeface) in place of those for Cys38, 92, 
116, 128, 183 and 281, respectively.  Additional primers, as follow respectively, changed 
Ala183 to serine, and Thr144, Asn236 and Lys337 to cysteines (altered codons in bold 
typeface): 
5′-GGTGAATGGAGTCAATTCCTTCATGCTGGACCCG-3′, 
5′-CAGAAAGAATTCATGCGATGAACCTTC-3′, 
5′-GTTTCCCCCAGACTGCTCAGCCCCCTAC-3′, and 
5′-CAGAAGCACGCAGCCTGCTGAAAACCTCAGCAGTTTATG-3′. 
A programmable theromocycler (BioRad iCycler) amplified mutant plasmids in a 
reaction volume of 50 µL.  Incubation of the reaction mixture with 20 U of DpnI for 2 hrs. 
at 37 °C removed the starting template, leaving mutated and nicked circular DNA.  5 µL of 
the incubation mixture was combined with 30 µL of chemically competent E. coli strain 
DH5α cells, left on ice for 30 min., heated for 45 sec. at 42 °C, and then cooled on ice for 2 
min.  Incubation of the resulting 35 µL culture with 1 mL of Luria broth for 2 hrs. at 37 °C 
completed the transformation.  Transformed cells were selected on Luria broth agar plates 
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with kanamycin (30 µg/mL).  Small volumes of Luria broth with kanamycin (30 µg/mL) 
were inoculated with single colonies and the cultures grown overnight.  The isolation of 
plasmids from over-night cultures employed the QIAprep Spin Miniprep kit.  Complete 
mutant vectors were than transferred to FBPase-deficient E. coli (DF657) for the expression 
of protein.  Mutations, and the integrity of the resulting gene, were confirmed by 
sequencing the promoter region and the entire open reading frame.  The Iowa State 
University sequencing facility performed all DNA sequencing, using the fluorescent dye 
dideoxy terminator method. 
Purification of the protein— Protocols for protein expression and purification are in the 
literature (19).  Recombinant FBPase was expreseed in FBPase-deficient E. coli (DF657).  
FBPase, eluted from Cibacron Blue-Sepharose chromatography, was adjusted to pH 7.5–8.3 
before loading onto a DEAE-Sepharose column (equilibrated with 5 mM MgCl2 and 20 mM 
Tris-HCl, pH 7.5).  FBPase eluted from DEAE-Sepharose was dialyzed against 20 mM 
Tris-HCl, pH7.5, and used immediately in experiments without freezing or storage.  Protein 
purity was monitored by SDS-PAGE (28)and protein concentrations determined by the 
method of Bradford (21). 
FBPase activity assay— Activity assays employed the coupling enzymes, 
phosphoglucose isomerase (10 µg/mL, 5units) and glucose-6-phosphate dehydrogenase (5 
µg/mL, 2units) (1).  All kinetic assays were performed at 22° C.  5 µg of FBPase construct 
was used in each assay of total volume 1 mL.  For assays that employed saturating levels of 
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Fru-1,6-P2, the reduction of NADP+ to NADPH was monitored by absorbance change at 340 
nm, using an extinction coefficient of 6.022x103.  For assays with non-saturating substrate, 
NADPH production was monitored by fluorescence emission at 470 nm using an excitation 
wavelength of 340 nm.  Initial velocity determinations at pH 7.5 for all mutant constructs 
employed 100 µM Fru-1,6-P2, 5 mM MgCl2, 150 mM KCl, 0.1 mM EDTA, 0.15 mM 
NADP+, and 50 mM HEPES, and such determinations at pH 9.5 used the same 
concentrations of reagents in 50 mM CAPS.  Maximal velocity scaled linearly with the 
amount of FBPase construct, indicating a sufficient excess of coupling enzyme under all 
conditions of assay. 
Determination of the Ka for Mg2+, the Km for Fru-1,6-P2, and the Hill coefficient for 
Mg2+ employed a 6x6 array of conditions that systematically varied the total concentration of 
Mg2+ from 1–50 mM and total concentration of Fru-1,6-P2 from 5–100 µM.  The 
concentration of free Mg2+ in assays is taken as its total concentration less the concentration 
of EDTA (0.1 mM).  Loss of free Mg2+ due to complexation with substrate was negligible.  
Determination of the concentration of free Fru-1,6-P2 employed a stability constant of 350 
for the binary complex of Mg2+ with substrate (29).  The determination of I0.5 for AMP 
(concentration of AMP that causes 50% inhibition) and the Hill coefficient for AMP 
employed 50 mM HEPES, pH 7.5, 50 µM Fru-1,6-P2, 5 mM MgCl2, 150 mM KCl, 0.1 mM 
EDTA, 0.15 mM NADP+, and AMP from 0.5–200 µM.  Determination of the 
concentrations of free AMP used a stability constant of 100 for the binary complex of Mg2+ 
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with nucleoside monophosphate. 
Data were fit to the following equation: 
V = Vmax/{([I]/I0.5)n + 1},           Equation 1 
where V and Vmax represent velocity and maximal velocity, [I] the concentration of AMP, 
I0.5 the concentration of AMP that causes 50% inhibition, and n the Hill coefficient for AMP.  
A similar expression is used to determine the Hill coefficient (n) for Mg2+, in which [I] 
represents the concentration of Mg2+ and I0.5 is the concentration of Mg2+ that causes 50% 
activation.  Values for kcat, Ka for Mg2+ and Km for Fru-1,6-P2 come from fits using the 
following equation: 
V = (Vmax•[M]2•[S])/( [M]2•[S] + Ka•[S] + Kb•[M]2 + Kia•Kib)   Equation 2 
where V represents velocity, Vmax maximum velocity, [S] the concentration of Fru-1,6-P2, 
[M] the concentration of Mg2+, [Eo] the total enzyme concentration, and kcat, the catalytic rate 
constant.  Equation 2 comes from a rapid-equilibrium Random model used in previous work 
(30).  All fits employed the program Grafit (31). 
Labeling of FBPase with fluorescent probe— Eosin-5-iodoacetamide (C22H10Br4INO6, 
Mr=830.84) was chosen as the fluorescent probe because of its high extinction coefficient 
(1x105 cm-1M-1, pH 7.5) at λmax=519 nm (32).  Fluorescence was monitored at the 
wavelength of maximum emission, 540 nm.  Solid eosin-5-iodoacetamide was desolved in 
dimethylformamide (DMF) to a concentration of 10 mM.  0.1 µmole of the desired FBPase 
mutant was incubated with 0.1 µmole of dithiothreitol (DTT) in 5 mL of Tris-HCl (20 mM), 
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pH 7.5 for 1 hour to fully activate the thiol groups.  1 µmole eosin-5-iodoacetamide (100 µL 
of 10 mM stock solution) was added, and the solution kept in darkness at 4° C for 12 hrs, 
with gentle rocking.  Passage the reaction mixture through a G25 Sepharose column 
(equilibrated and run with Tris-HCl (20 mM), pH 7.5 at rate ~1ml/min) separated modified 
protein (first UV-absorbing peak) from unreacted probe.  Bradford method (absorbance 
corrected for the attached probe) was used to check the protein concentration, and the 
quantity of attached probe was determined by its absorbance at 519 nm and known 
coefficient extinction. 
Time-dependent Fluorescence Assays— Fluorescence data were collected using a SLM 
8100C fluorimeter from Spectronic Instruments, using an excitation wavelength 519 nm was 
and an emission wavelength at 540 nm.  Each datum was recorded for a time span of 1 
minute.  All measurements came from freshly prepared enzyme; enzyme with or without 
probes was never frozen.  (The reason for this is discussed in the results section). 
Two kinds of experiments were performed: the dilution of labeled enzyme and subunit 
exchange between labeled and unlabeled enzyme.  In the former experiment, labeled 
FBPase at a concentration of 5.0 µM in Tris-HCl (20 mM), pH 7.5, was mixed (10 seconds 
of manual mixing in a 2 mL cuvette) with Tris-HCl (20 mM), pH 7.5 to give final protein 
concentrations from 0.1 to 0.6 µM.  Fluorescence changes with time were recorded over a 
period of 24 hrs.  Specific activities of the enzyme were determined at the beginning and at 
the end of each experiment.  Data from the dilution experiments determined Keq governing 
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the equilibrium between dimers and tetramers (or monomers and dimers), as well as response 
constants for the difference in fluorescence emission between the self-quenched construct 
and the construct without self-quenching.  Time-dependent fluorescence changes due to 
subunit exchange employed probe-labeled FBPase, pre-equilibrated with Tris-HCl (20 mM), 
pH 7.5, at a final concentration of either 0.125 or 0.25 µM.  1.95 mL of the equilibrated 
probe-labeled FBPase was combined with 50 µL of wild-type FBPase.  Ratios of 
probe-labeled FBPase to wild-type FBPase were 1:1, 1:4 and 1:8.  Time-dependent 
fluorescence exchange experiments were done in triplicate.  Ligands such as AMP, Fru-6-P 
or Mg2+, were added to probe-labeled FBPase at the onset of pre-equilibratioon with 
Tris-HCl (20 mM), pH 7.5. 
Analysis of Time-dependent Fluorescence Data— Programs Grafit (31) and Dynafit (33) 
were used for fitting equilibrium and kinetics models, respectively.  Details of the analysis 
are provided in the results section. 
RESULTS 
Rationale for directed mutations—Six cysteines are in wild-type FBPase (Figure 1).  
Over an incubation of 24 hrs., four mole equivalents of cysteine react with DTNB in the 
absence of ligands and three mole equivalents react with DTNB in the presence of AMP and 
Fru-2,6-P2.  AMP binds to an allosteric site, stabilizes the quaternary T-state of FBPase, and 
arrest subunit exchange (14, 20, 21), and Fru-2,6-P2 binds synergistically with AMP at the 
active site favoring a T-like quaternary state (16, 34).  Evidently, a subset of cysteines in 
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wild-type FBPase could react with the fluorescent probe.  Sequence alignments of FBPase 
sequences revealed alanine, serine, and in some instances lysine at positions corresponding to 
Cys38, 92, 116, 128, 183, and 281.  Substitution of the aforementioned cysteines with 
alanine would have a reasonable prospect of producing a tetramer with functional properties 
similar to that of the wild-type enzyme.  Ala(38,92,116,128,183,281) FBPase, however, 
could not be isolated.  Constructs with partial substitutions of alanine for cyteine were 
stable and active, and from these the mutation of Cys183 to alanine seemed the source of the 
problem.  The mutation of Cys183 to alanine would create a void in the tightly packed 
hydrophobic interior of the subunit.  Such voids can destabilize a structure by as much as 7 
kcal/mole(35).  Position 183 was changed to serine, and the resulting mutant FBPase 
exhibited substantial activity.  Hereafter, the construct Cys38, 92, 116, 128, 281→Ala and 
Cys183→Ser is called Cys° FBPase. 
Cysteine residues engineered into Cys° FBPase serve as specific sites for the covalent 
attachment of the fluorescent probe.  Asn236 and Thr144 are surface side chains near the 
C1-C2 and C1-C4 interfaces, respectively, whereas Lys337 is at the C-terminus and remote 
from any interface (Figure 1).  Distances between the Sγ atoms of cysteines at positions 144, 
236, and 337 are in Table 1.  Probes attached to Cys144 should be sensitive to disruption of 
the C1-C4 interface, but insensitive to changes at the C1-C2 interface.  Conversely, probes 
attached to Cys236 should be sensitive to changes at the C1-C2 interface, but not the C1-C4 
interface.  Modification of Cys337 puts fluorescent probes at large separations.  Hence, 
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probe-modified Cys337 should be insensitive to changes at either the C1-C2 or C1-C4 
interfaces.  Positions 144, 236 and 337 sites are not part of any known ligand bind site of 
porcine FBPase, although position 144 is adjacent to the AMP binding pocket. 
Properties of FBPase Constructs— Wild-type and mutant proteins behaved identically 
throughout purification and were at least 95% pure by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis (data not shown).  The ratio of catalytic rates at pH 7.5/9.5 (Table 1) is a 
sensitive indicator of proteolysis of mammalian FBPases.  A value of 3 or above indicates 
an intact enzyme, whereas a value of 1.6 or less indicates at least one subunit of the tetramer 
has undergone proteolysis.  Mutations that impair the function of the critical catalytic loop 
of FBPase also exhibit low activity ratios (18, 20). 
The kcat parameters of all constructs are 20–30% of that of the wild-type enzyme.  The 
activity loss is linked to Cys° FBPase, and may be due to the mutation of Cys128 which is 
near the active site and the C1-C2 interface (Figure 1).  Reduced activity may result from 
the 10-fold increase in the Ka for Mg2+ in Cys° FBPase.  Modifications have weakened 
metal association with the active site, but the Hill coefficient for Mg2+ remains close to that 
of the wild-type enzyme.  Work of Nelson et al. (30) attributed cooperativity in 
Mg2+-activation of FBPase to the binding of metal ions to the same active site within a 
subunit.  Hill coefficients near 1.9 are consistent with the binding of metal ions to sites 2 
and 3, with site 1 fully occupied at concentrations of free Mg2+ much less than the minimum 
concentration used in assays (36, 37).  The weaker interaction with the active site, however, 
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necessitated elevated concentration of Mg2+ in assays which lead to significant formation of 
Mg2+•Fru-1,6-P2 complexes.  The Km for Fru-1,6-P2 based on the total concentration of 
substrate increased systematically as the fixed concentration of Mg2+ increased.  Subtracting 
amount of total substrate in the form of binary complexes of Mg2+•Fru-1,6-P2, and using the 
free concentration of Fru-1,6-P2 provided consistent values for the Km of Fru-1,6-P2 listed in 
Table 2. 
The Hill coefficient for inhibition by AMP indicates modest perturbation due to the 
mutation of The144→Cys, and still more significant perturbation as a consequence of 
modifying the enzyme with the fluorescent probe.  Sufficient concentrations of AMP, 
however, still cause complete inhibition consistent with the behavior of the wild-type enzyme 
(14). 
The extent of labeling of FBPase constructs was taken as the ratio of the concentration of 
covalently attached probe (as measured by absorbance at 519 nm) to the concentration of 
protein given by the Bradford assay.  All constructs exhibited labeling at their theoretical 
maximum levels of 100±6%. 
Subunit Dissociation by Dilution— Dilution of labeled FBPase will change the ratio of 
tetramers, dimers and monomers in the solution.  Time-dependent fluorescence change 
results from the slow approach to equilibrium.  In order to monitor whether dissociation 
occurs by way of a series pathway (for instance, loss of the C1-C4 interface, followed by loss 
of the C1-C2 interface) or by a parallel pathway (loss of the C1-C4 and C1-C2 interfaces by 
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comparable time-courses), the attached probes must provide information about the integrity 
of one interface only.  Probe molecules (we hypothesize) at a distance of separation of 
approximately 40 Å interact, whereas at a distance of 100 Å they do not.  Dilution of 
probe-modified Cys°337 FBPase is a negative control, and should be insensitive to changes 
at the C1-C4 and C1-C3 interfaces, and perhaps insensitive to changes in the C1-C2 interface 
(Table 1).  Indeed, no time-dependent change in fluorescence is evident upon dilution of 
Cys°337 FBPase (Figure 2a). 
Dilution of probe-modified Cys°144 FBPase should be sensitive to changes at the C1-C4 
interface and no other (Table 1).  In the absence of ligands or in the presence of Fru-6-P, an 
immediate and virtually identical time-dependent increase in fluorescence is evident in 
Figure 2b.  On the other hand, no increase in fluorescence occurs with time in the presence 
of AMP.  These findings are consistent with an arrest of subunit exchange by AMP, and that 
Fru-6-P has no effect on the stability of the C1-C4 interface (21). 
Dilution of probe-modified Cys°236 FBPase should be sensitive to changes at the C1-C2 
interface alone (Table 1).  In the absence of ligands, a time lag of approximately 30 minutes 
occurs before time-dependent fluorescence changes begin (Figure 2c).  Moreover, AMP or 
Fru-6-P abolishes time-dependent fluorescence change.  Hence AMP and Fru-6-P arrest 
disruption or stabilize the C1-C2 interface.  The observation of a time-lag before the onset 
of fluorescence change is consistent with a serial pathway in which the loss of components 
with an intact C1-C2 interface depends on a preceding event.  That event presumably is the 
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dissociation of the tetramer into C1-C2 dimers (the loss of components with an intact C1-C4 
interface).  The proposed mechanism of subunit exchange and subunit dissociation is in 
Scheme I. 
Determination of Rate Constants for the Tetramer to Dimer Dissociation— The 
qualitative findings above are consistent with an equilibrium between tetramers and C1-C2 
dimers and a second equilibrium between C1-C2 dimers and monomers.  An equilibrium 
between tetramers and trimers/monomers would not account for the time-lag in the loss of 
components with C1-C2 interfaces.  At elevated concentrations (200 µg/mL), FBPase is 
overwhelmingly a tetramer.  Hence, we assume the predominance of the tetramer, with the 
formation of some C1-C2 dimer.  Loss of the C1-C2 dimer due to further dissociation into 
monomers is assumed negligible.  At low concentrations of fluorophore, fluorescence is 
linearly proportional to the concentration; however, because of self-quenching the 
proportionality constant will differ for the various components.  For instance, for 
probe-modified Cys°144 FBPase, self-quenching occurs in the tetramer, but not in the C1-C2 
dimer or the monomer. 
The fluorescence at low concentrations of total protein then scales linearly with the 
concentration of tetramer and dimer: 
F = aT + bD               Equation 2 
where a and b are proportionality constants and T and D are concentrations of tetramer and 
dimer.  As the stock solution of probe-modified Cys°144 FBPase is primarily tetramer, 
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fluorescence emission from various dilutions of the stock solution taken at time zero (before 
equilibration and further dissociation of the tetramer) should vary linearly with total protein 
concentration.  Indeed this is the case (Figure 3) where the slope of an F vs. T plot 
represents an accurate measure of the proportionality constant a.  No method is available, 
however, for the direct measurement of the constant b, as dimers in the absence of tetramers 
occurs only at infinite dilution. 
The time-dependent change in fluorescence of a rapidly diluted stock solution of the 
tetramer can provide sufficient data for a reasonable estimate of a, b and rate constants k1 for 
the dissociation of tetramer to dimer and k2 for the association of dimer to tetramer.  The 
time-dependent fluorescence change associated with six different dilutions of probe-modified 
Cys°144 FBPase (Figure 3) can be modeled in Dynafit.  As is evident from Table 3, 
parameter a is close to the value determined from a plot of initial fluorescence vs. the total 
concentration of protein as tetramer.  Parameters b, k1, and k2 have appreciably higher levels 
of uncertainty due in part to the correlation between parameter b and the k1/k2 (that is, Keq). 
Irrespective of the uncertainty in parameters b, k1 and k2, they provide accurate 
predictions of the outcome of two distinct experiments.  The measurement of fluorescence 
emission from different concentrations of probe-modified Cys°144 FBPase at time zero 
(immediately upon dilution) and after equilibration (24 hrs.) conforms to the following: 
∆F = a∆T + b∆D             Equation 2 
Where ∆T and ∆D represent the change in concentrations of tetramer and C1-C2 dimer, 
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respectively, a and b the corresponding proportionality constants, and ∆F the change in 
fluorescence.  The final concentrations of tetramer (Tf) and dimer (Df) are given by a simple 
equilibrium expression: 
 Tf = Df2/Keq                  Equation 3 
Where Keq is a dissociation constant for the tetramer into dimers.  Similarly, the stock 
solution of protein prior to dilution is at equilibrium: 
 Tstock = (Dstock)2/Keq             Equation 4 
The initial concentrations of tetramer and dimer immediately upon dilution (Ti and Di, 
respectively) equal d*Tstock and d*Dstock, where d is a dilution factor.  Expressing ∆T as 
Tf–d*Tstock and ∆D as Df–d*Dstock, substitution of Equations 3&4 in Equation 2 gives  
 ∆F = (a/Keq)*{Df2 – d*Dstock2} + b*{Df – d*Dstock}      Equation 5 
The concentrations Df and Di are not known, but can be related to the total concentration 
of protein as tetramer in the final solution (T0) and in the stock (T0stock): T0stock=Tstock + 
½Dstock and T0=Tf + ½Df.  Substitution of Equations 3&4 for Tf and Tstock results in 
quadratic equations, one in terms of Df and the other in terms of Dstock.  Solutions to these 
quadratic equations are given by the quadratic formula: 
Df = –Keq/4 + (Keq2/16 + Keq*T0)1/2 and Dstock = –Keq/4 + (Keq2/16 + Keq*T0stock)1/2 
Substitution of these into Equation 5 directly relates an observed fluorescence change 
(∆F) to the known total concentration of protein as tetramer (T0):  
∆F = (a/Keq)*{[–Keq/4 + (Keq2/16 + Keq*T0)1/2]2 – d*[–Keq/4 + (Keq2/16 + Keq*T0stock)1/2]2} 
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+ b*{[–Keq/4 + (Keq2/16 + Keq*T0)1/2] – d*[–Keq/4 + (Keq2/16 + 
Keq*T0stock)1/2]} 
                      Equation 6 
In Equation 6, proportionality constants, a and b are the equilibrium constant Keq=k1/k2 
are available from Dynafit.  The dilution factor d and total concentration of the protein as 
tetramer in the stock solution T0stock are known.  Hence Equation 6 determines an expected 
∆F which can be compared to observed values (Figure 4). 
A second test of parameters in Table 3 is their prediction of the time-dependent 
fluorescent change in subunit exchange experiments.  In these experiments, total protein is 
constant, and it is the exchange of dimers between tetramers that diminishes self-quenching 
of the fully-labeled tetramer.  The observed and modeled time courses (using Dynafit with 
fixed values for the four parameters) are again in agreement (Figure 5). 
Determination of Rate Constants for the Dimer to Monomer Dissociation— In Scheme I, 
dimer dissociation to monomer follows the tetramer.  Only the dimer-monomer 
dissociation/association influences fluorescence of probe-modified Cys°236 FBPase.  
Dissociation of the tetramer to dimer by disruption of the C1-C4 interface does not disrupt 
the self-quenching relationship of probe molecules juxtaposed with respect to the C1-C2 
interface (Figure 1).  Hence, fuorescence is related to concentrations of tetramer T, dimer D, 
and monomer M through prpportinality constants a, b, and c: 
F = a*T + b*D + c*M.            Equation 7 
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As before, an estimate of a comes from a plot of fluorescence vs. total protein 
concentration as tetramer.  Two dimer form from one tetramer, hence into to have no in 
fluorescence due to the conversion of tetramer into dimer, b = (½)a.  Using values for k1 and 
k2 determined from probe-modified Cys°144 FBPase, a fit of the time-dependent change in 
fluorescence (Figure 6) using a, c, k3 and k4 as adjustable parameters results in the values of 
Table 4.  Using Dynafit, k1 and k2 from Table 3 and a, c, k3, and k4 from Table 4, simulation 
of time-dependent fluorescence change in the subunit-exchange reaction between 
probe-modified Cys°236 FBPase and wild-type enzyme closely follows the observed change 
in fluorescence (Figure 7). 
DISSCUSION 
The application of self-quenching has a drawback common to all techniques that 
introduce a non-native probe: the probe must be a reporter group, providing information 
without influencing function.  Detailed information regarding ligand binding sites and the 
structure of FBPase facilitated the design of experiments, determining the optimal placement 
of probes so as to enhance self-quenching without significantly perturbing properties of 
kinetics (Table 2).  A distinct advantage of self-quenching lies in its simplicity: it avoids 
complications due to the overlap of fluorescence emissions from donor and acceptor, a 
concern in fluorescence resonance energy transfer (FRET) experiments.  Moreover, the 
self-quenching approach requires the covalent coupling of only one type of fluorophore, 
whereas FRET requires two fluorophores with properly paired absorbance and emission 
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properties.  A drawback lies in the absence of a quantitative relationship between probe 
separation and the extent of self-quenching, which is circumvented here by the use of a 
negative control (Figure 2) that clearly demonstrates the absence of self-quenching at probe 
separations in excess of 60 Å. 
Other applications of self-quenching are in the literature.  A decrease in fluorescence 
emission intensity attends the dimerization of leucine zipper constructs, to which fluorescein 
is attached (26).  Conversion of the dimer to the monomer increased fluorescence.  The 
determination of forward and reverse rate constants in the dimer/monomer equilibrium were 
determined from fluorescence changes that occurred subsequent to rapid dilution and 
exchange reactions between labeled and nonlabled constructs.  Chu et al. (27) used 
self-quenching to monitor the refolding of a single molecule of titan, a protein of ~30,000 
amino acids.  Fluorescence emission decreases as labeled and denatured titan refolds to its 
native state. 
The formation of tetramer hybrids of FBPase through subunit exchange have provided 
new tools in the exploration of cooperativity in AMP inhibition (38) and Mg2+ activation (30) 
of the wild-type tetramer.  The process of subunit exchange between a polyglutamyl-tagged 
homotetramer of FBPase and an untagged tetramer produces seven species (20).  DEAE 
chromatography readily separates tetramers with no tagged subunits, one tagged subunit, 
three-tagged subunits and four tagged subunits; however, three distinct hybrid tetramers with 
two tagged subunits separates into a single peak and an unresolved doublet.  Assignment of 
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the correct two-tagged tetramer to the single peak is critical to the valid interpretation of 
experimental results, particularly those dealing with the mechanism of AMP cooperativity 
(20, 38, 39) 
In the presence of Fru-6-P, Fru-1,6-P2 or Fru-2,6-P2, Nelson et al. (20, 21) observed only 
three species: tetramers with no tagged subunits, tetramers with four tagged subunits, and a 
peak matching the retention time of the resolved tetramer with two tagged subunits.  As the 
6-phosphoryl binding pocket involves residues from subunits C1 and C2, Nelson et al. 
accounted for the absence of tetramers with one tagged and three tagged subunits by a 
mechanism of C1-C2 dimer exchange in the presence of active site ligands.  By this 
reasoning, the tagged subunits in the resolved two tagged tetramer are in the same C1-C2 
dimer.  Recent work of Slebe and co-workers (40), however, suggests that in the presence of 
high concentrations of guanidinium chloride, the C1-C2 interface becomes solvent exposed 
before the C1-C4 interface (40).  The uncertainty over the relative stability of subunit 
interfaces in FBPase in the absence of a denaturant, in part motivated the present 
investigation. 
Studies here show unequivocally the stabilization of the C1-C2 interface by Fru-6-P, and 
the stabilization of the C1-C2 and C1-C4 interfaces by AMP.  The effect of AMP is 
consistent with an ordered pathway of subunit dissociation.  If loss of the C1-C4 interface 
must precede the loss of the C1-C2 interface, then ligand stabilization of the C1-C4 interface 
must also stabilize the C1-C2 interface.  Conversely in an ordered pathway, the stabilization 
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of the C1-C2 interface by Fru-6-P should have no effect on the stability of the C1-C4 
interface, as clearly indicated from the data from Figure 2B showing equivalent 
time-dependent increases of fluorescence in the presence and absence of Fru-6-P.  As 
mentioned in the results section, the time lag before the appearance of fluorescence change in 
Figure 2C is consistent with the breakdown of tetramers into C1-C2 dimers prior to the 
dissociation of C1-C2 dimers into monomers.  No evidence here suggests the loss of the 
C1-C2 interface directly from the tetramer.  Such a pathway would generate an immediate 
rise in fluorescence in Figure 2C upon dilution of probe-modified Cys°236 FBPase, which is 
not evident from the data.  Finally, the rate and proportionality constants determined in the 
results section also adequately account for the time-dependent fluorescence change due to the 
exchange of subunits between probe-modified constructs and wild-type FBPase.  Of note is 
the assumption of the same set of rate constants for all constructs in Scheme I, which appears 
valid in simulations of exchange phenomenon. 
The mechanism of ligand stabilization of the C1-C2 interface is clear from structures of 
FBPase, which reveal hydrogen bonds between the 6-phosphoryl group of Fru-6-P and 
residues from subunits C1 and C2.  But how does AMP abolish exchange processes 
altogether?  AMP transforms FBPase into the T-state, whereas Fru-6-P and Fru-6,2-P2 
stabilize porcine FBPase in the R-state and a T-like state (called IT (16)), respectively.  
Fru-6-P and Fru-2,6-P2 do not abolish dimer exchange via the loss of the C1-C4 interface 
even though each active site ligand stabilizes a different quaternary of the tetramer.  The 
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disassembly of the tetramer into C1-C2 dimers may occur from a conformational state of 
FBPase readily accessible to the R- and IT-states, but not to the T-state AMP complex. 
The binding of AMP causes a shear between helices H1 and H2 within the FBPase 
subunit (15), and may result in a better fit of helices H1 and H2 with their symmetry related 
mates across the C1-C4 interface.  In addition, AMP through its hydrogen bonding 
interactions may limit the dynamic motion of helices H1 and H2, increasing the depth and 
steepness of the potential energy well of the T-state relative to the IT-state (Figure 8).  
Perhaps in the absence of AMP, FBPase is in rapid exchange between its R- and IT-states.  
In other words, a low energy barrier divides the two states, but as the tetramer crosses this 
barrier, interactions at the C1-C4 interface become weak.  Glu192, critical to hydrogen 
bonds across the C1-C4 interface, undergoes a conformational change between the R- and 
T-states which may result in the transitory loss of hydrogen bonds (15).  The forward and 
reverse rates in the tetramer/dimer equilibrium would be high relative to the wild-type 
enzyme in mutant FBPases that favor the intermediate states of the tetramer. 
An ordered pathway of subunit exchange is also consistent with the properties of the 
Type I FBPase from Escherichia coli (16, 34, 41, 42).  E. coli FBPase has an allosteric 
activation site at the C1-C4 interface of the tetramer. The activation site favors anions in 
general, and phosphoenolpyruvate or citrate specifically (34, 42).  In the absence of anions, 
however, the E. coli enzyme transforms into a species with a mass comparable to that of a 
dimer (42).  These observations regarding the Type I FBPase from E. coli are consistent 
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with a tetramer/dimer equilibrium in which C1-C2 dimers form due to a weakened C1-C4 
interface in the absence of anions.  The possibility of a common pathway of dissociation for 
enzymes as evolutionary distinct as those from pig and E. coli suggest that the labile 
characteristics of theC1-C4 interface may be a general property of FBPases regardless of 
source. 
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Table 1.  Characteristic distances (in Å) between probe molecules.  The χ1 angle of the 
cysteine residue adopts a favored minimum energy conformer that allows the fluorescent 
probe to extend away from the surface of the enzyme.  Distances are taken in the R-state 
structure between the Sγ atom of the cysteine from subunit C1 to corresponding Sγ atoms of 
subunits C2, C3 and C4. 
FBPase Construct Distance C1-C2 Distance C1-C3 Distance C1-C4 
Cys°144 89 91 39 
Cys°236 37 104 97 
Cys°337 59 127 116 
 
 Table 2.  Kinetics of FBPase mutants.  Cys° FBPase replaces Cys38, 92, 116, 128, and 281 with alanine, and Cys183 with 
serine.  Cys°144 FBPase, Cys°236 FBPase, and Cys°337 FBPase are single mutations of Cys° FBPase in which cysteine replaces 
Thr144, Asn236 and Kys337, respectively. Assay conditions and definitions of kinetic parameters are in the experimental section. 
 
Enzyme type 
Wild-type
FBPasea 
Cys° 
FBPase 
Cys°144
FBPase 
Cys°236
FBPase 
Cys°337
FBPase 
Cys°144
FBPase 
Probe 
modified
Cys°236
FBPase 
Probe 
modified
Cys°337
FBPase 
Probe 
modified
kcat (sec–1) 22±1 6.7±0.49 7.1±0.54 3.8±0.14 4.9±0.41 6.5±0.31 4.1±0.17 3.7±0.14
Activity ratio, pH 7.5:9.5 3.3 3.1 3.31 3.0 3.37 3.1 3.12 3.2 
Ka – Mg2+ (mM)b 0.67±0.04 8±1 8±1 4.1±0.5 8±1 3.6±0.4 3.9±0.4 3.6±0.3 
Hill Coefficient, Mg2+b 1.9±0.1 1.5±0.1 1.5±0.1 1.6±0.1 1.4±0.1 1.7±0.2 1.6±0.09 1.7±0.2 
Km – Fru-1,6-P2 (µM)b 1.8±0.1 6±1 7±1 3.0±0.4 8±1 3.6±0.4 2.9±0.4 4.4±0.3 
I0.5 – AMP (µM) 1.61±0.05 6.4±0.6 3.4±0.3 4.7±0.2 3.4±0.2 33±5 4.7±0.3 9±1 
Hill Coefficient, AMP 2.2±0.1 2.0±0.3 1.3±0.2 1.8±0.1 1.45±0.09 1.2±0.3 1.8±0.2 1.4±0.2 
 
Table 2.  Footnotes. 
aData from reference (20). 
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Table 3: Parameters from the time-dependent change in fluorescence due to the dilution 
of probe-modified Cys°144 FBPase.  Data from Figure 3 are fit by differential equations 
dF/dt = a*dT/dt + b*dD/dt, where F is the observed fluorescence, and T and D are the 
concentrations of tetramer and dimer, respectively.  dT/dt = (½)dD/dt = –k1*T + k2*D2, 
where parameters a, b, k1 and k2 are defined in the results section. 
 
Parameter Fitted value Error (%) 
k1 (min–1) 0.0029±0.0006 21.0 
k2 (min–1M–1) 0.06±0.01 21.5 
a (Arbitrary fluorescence units*min–1) 2.13±0.004 0.2 
b (Arbitrary fluorescence units*min–1) 3.2±0.4 12.8 
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Table 4: Parameters from the time-dependent change in fluorescence due to the dilution 
of probe-modified Cys°236 FBPase.  Data from Figure 6 are fit by differential equations 
dF/dt = a*dT/dt + b*dD/dt + c*dM/dt, where F is the observed fluorescence, and T, D, and M 
are the concentrations of tetramer, dimer, and monomer respectively.  dT/dt = (½)dD/dt = 
–k1*T + k2*D2, where parameters k1 and k2 are those from Table 3.  dD/dt = (½)dM/dt = 
–k3*D + k4*M2, where parameters k3 and k4 are defined in the results section.  Parameters a 
and b do not assume the values of Table 3, but for probe-modified Cys°236 FBPase, b = (½)a, 
where a is approximated by the slope of a linear plot of F vs. T at time zero. 
 
Parameter Fitted value Error (%) 
k3 (min–1) 0.020±0.003 17.1 
k4 (min–1M–1) 0.49±0.06 12.8 
a (Arbitrary fluorescence units*min–1) 2.205±0.04 0.2 
c (Arbitrary fluorescence units*min–1) 1.7±0.1 8.3 
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FIGURE LEGENDS 
Figure 1.  Overview of the FBPase tetramer.  Filled circles indicate positions of the Cα 
atoms of cysteine residues, Thr144, Asn236 and Lys337.  Wireframe models represent 
bound AMP and Fru-6-P at the allosteric inhibition and active sites, respectively.  The 
symmetry unique interfaces of FBPase (C1-C2, C1-C3, and C1-C4) are between subunits 
bearing the same labels. 
Figure 2.  Time-dependent changes in fluorescence subsequent to the dilution of 
probe-labeled FBPase.  50 µL of a stock solution of 20 µM probe-modified FBPase in 
Tris-HCl, pH 7.5, was diluted at 25 °C into 1950 µL of the same buffer without protein and 
with and without AMP and/or Fru-6-P.  Fluorescence was monitored continuously for 2 hrs.  
A. Probe-modified Cys°337 FBPase with 1 mM AMP (■), with 1 mM Fru-6-P (◇) and 
without ligands (●).  B. Probe-modified Cys°144 FBPase with 1 mM AMP (■), with 1 
mM Fru-6-P (◇) and without ligands (●).  C. Probe-modified Cys°236 FBPase with 1 mM 
AMP (■), with 1 mM Fru-6-P (◇) and without ligands (●). 
Figure 3.  Time-dependent changes in fluorescence subsequent to varying dilutions of 
probe-labeled Cys°144 FBPase.  Variable (from 40 to 240 uL) stock solution of 20 µM 
probe-modified FBPase in Tris-HCl, pH 7.5, was diluted at 25 °C into the same buffer to a 
total volume 2 mL without protein and with and without AMP and/or Fru-6-P.  Fluorescence 
was monitored continuously for 2 hrs.  The lines represent calculated fluorescence values 
based on the parameters of Table 3.  Points represent data selected arbitrarily at 
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three-minute intervals.  Inset: Plot of fluorescence F versus the total concentration of 
tetramer T0 at time zero.  Slope of the plot approximates a to the extent that all protein is 
tetramer. 
Figure 4.  Total fluorescence changes due to varying dilutions of probe-modified 
Cys°144 FBPase.  Variable (from 25 to 200 uL) stock solution of 20 µM probe-modified 
FBPase in Tris-HCl, pH 7.5, was diluted at 25 °C into the same buffer to a total volume 2 mL 
without protein and with and without AMP and/or Fru-6-P.  Fluorescence was measured 
right after dilution and after equilibrium (24hrs).  The line represents calculated 
fluorescence change based on the parameters of Table 3 and Equation 6. 
Figure 5.  Fluorescence change due to subunit exchange between probe-modified 
Cys°144 FBPase and wild-type FBPase.  1.95 mL of a stock solution of 0.5 µM 
probe-modified FBPase in Tris-HCl, pH 7.5, 1 mM Fru-1,6-P2 was mixed with 50µL of stock 
solution of 20 µM wild-type FBPase in same buffer at 25 °C.  Fluorescence was monitored 
continuously for 2 hrs.  The solid line represents the calculated fluorescence based on the 
parameters of Table 3.  Points represent data selected arbitrarily at three-minute intervals. 
Figure 6.  Time-dependent changes in fluorescence subsequent to varying dilutions of 
probe-labeled Cys°236 FBPase.  Variable (from 12.5 to 75 uL) stock solution of 20 µM 
probe-modified FBPase in Tris-HCl, pH 7.5, was diluted at 25 °C into the same buffer to a 
total volume 2 mL without protein and with and without AMP and/or Fru-6-P.  Fluorescence 
was monitored continuously for 2 hrs.  The lines represent calculated fluorescence values 
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based on the parameters of Tables 3&4.  Points represent data selected arbitrarily at 
three-minute intervals. 
Figure 7.  Fluorescence change due to subunit exchange between probe-modified 
Cys°236 FBPase and wild-type FBPase.  1.95 mL of a stock solution of 0.65 µM 
probe-modified FBPase in Tris-HCl, pH 7.5, was mixed with 50 µL of stock solution of 208 
µM wild-type FBPase in same buffer at 25 °C.  Fluorescence was monitored continuously 
for 2 hrs.  The solid line represents the calculated fluorescence based on the parameters of 
Tables 3&4.  Points represent data selected arbitrarily at three-minute intervals. 
Figure 8.  Energy relationships of the known quaternary states of FBPase.  The 
ordinate represents the rotation of subunit pair C1-C2 relative to C3-C4 in the quaternary 
state, with the R-, IT- and T-states having 0, 13, an 15° subunit pair rotations.  Dissociation 
of C1-C2 dimers from the tetramer may occur at the height of the energy barrier between R 
and IT-states. 
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Fig. 1.  Zhou, et al. 
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Fig. 2.  Zhou, et al. 
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Fig. 3.  Zhou, et al. 
 
 
 
 
 
 
 
Fig. 4.  Zhou, et al. 
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Fig. 5.  Zhou, et al. 
 
 
 
 
 
 
Fig. 6.  Zhou, et al. 
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Fig. 7.  Zhou, et al. 
 
 
 
 
 
 
Fig. 8.  Zhou, et al. 
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CHAPTER V. GENERAL CONCLUSION 
The affinity of ligands to protein is determined by many factors such as size, shape and 
plasticity; however, the effect of cavities on ligand recognition is often overlooked. Using 
adenylosuccinate synthetase (ADSS) as a model, we test the effect of an induced-fit cavity on 
ligand affinity.  Both IMP and 2′-deoxy-IMP serve as good substrates in ADSS and forming 
expected intermediates and producrs.  Crystal structures of the intermediate complexes are 
identical except for the presence/absence of the 2′-hydroxyl group.  However, ADSS shows 
significantly different affinities for L-aspartate in the presence of IMP and 2′-deoxy-IMP.  
Using Lennard-Jones 6-12 model, we get a 2 kcal/mole decrease in energy in the absence of 
the hydroxyl group.  According to thermodynamics formula ∆G = –RTlnK, we estimate a 
~40 fold affinity difference, which is consistent with our experiment data.  Such a model 
illustrates that an induced cavity can contribute significantly to the recognition of ligands. 
 The recognition of L-aspartate by Valine273 in ADSS is very interesting since it is a 
non-polar amino acid and not capable of forming hydrogen bonds or coordinate bonds with 
metal cations.  However, the mutations of Valine273 to threonine, alanine and asparagine 
increase the Km for L-aspartate from 15-40 folds.  Sequence alignments reveal Valine273 as 
an invariant residue, not altered through evolution.  Crystal structures of mutant 
Threonine273 and Alanine273 ADSS with and without ligands reveal different contributions in 
the poor recognition of L-aspartate.  Threonine273, which introduces a polar side chain into 
the active site, induces a confirmation change of L-aspartate loop (299-304).  The loop 
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closes on the active site making access to the active site difficult for L-aspartate.  The 
change of Valine273 to alanine, on the other hand, creates empty space in the active site, 
allowing Arginine305 to drifts into the active site again sterically blocking L-aspartate.  
Asparagine273 occupies extra space in the active site and interacts with neighboring amino 
acids.  All the factors above determine Valine273 is the only residue that maintains the 
correct structure of the active site without causing steric restrictions in the binding of 
L-aspartate. 
Determining the pathway of subunit exchange in FBPase confirms the assignment of 
hybrid constructs of FBPase, which form the basis for proposed mechanisms of cooperativity 
in AMP association.  By attaching probes at specific positions and monitoring 
time-dependent fluorescence change due to changes in self-quenching in dilution and subunit 
exchange experiments, we are able to elucidate the pathway of dissociation of the FBPase 
tetramer.  FBPase dissociates by way of an ordered pathway with the formations of C1-C2 
dimer, followed by the the breakdown of C1-C2 dimers into omonomers.  Furthermore, 
fiting the time dependence of fluorescence to the ordered pathway of dissociation determined 
numerical values for rate constants that allow accurate simulations of data gotten from 
subunit exchange experiments.  The results firmly establish the mechanism of subunit 
exchange dynamics of FBPase in vitro and may provide a valuable tool in probing rates of 
quaternary transitions in FBPase.  The approach here may in fact be broadly applicable to 
the study of subunit dissociation of other complex biological systems for which adequate 
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structural information is available. 
